<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id>
<journal-title>Frontiers in Cellular and Infection Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell. Infect. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">2235-2988</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcimb.2025.1647652</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cellular and Infection Microbiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Identification of the <italic>wbtF</italic> gene as a cytotoxicity-associated factor in <italic>Francisella novicida</italic> infection</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Wardhana</surname>
<given-names>Dhandy Koesoemo</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3151689/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" corresp="yes" equal-contrib="yes">
<name>
<surname>Shimizu</surname>
<given-names>Takashi</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/222212/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Watanabe</surname>
<given-names>Kenta</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/276098/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Uda</surname>
<given-names>Akihiko</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1077601/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Watarai</surname>
<given-names>Masahisa</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/255645/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Laboratory of Veterinary Public Health, Joint Graduate School of Veterinary Medicine, Yamaguchi University</institution>, <addr-line>Yamaguchi</addr-line>, <country>Japan</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Division of Veterinary Public Health, Department of Veterinary Science, Faculty of Veterinary Medicine, Universitas Airlangga</institution>, <addr-line>Surabaya</addr-line>, <country>Indonesia</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Veterinary Science, National Institute of Infectious Diseases</institution>, <addr-line>Tokyo</addr-line>, <country>Japan</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/423509/overview">Nicolas Jacquier</ext-link>, Centre Hospitalier Universitaire Vaudois (CHUV), Switzerland</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/501440/overview">Petra Spidlova</ext-link>, University of Defence, Czechia</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/196351/overview">Thomas Robert Laws</ext-link>, Defence Science and Technology Laboratory, United Kingdom</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Takashi Shimizu, <email xlink:href="mailto:shimizut@yamaguchi-u.ac.jp">shimizut@yamaguchi-u.ac.jp</email>
</p>
</fn>
<fn fn-type="equal" id="fn003">
<p>&#x2020;These authors have contributed equally to this work</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>09</day>
<month>10</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>15</volume>
<elocation-id>1647652</elocation-id>
<history>
<date date-type="received">
<day>16</day>
<month>06</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>19</day>
<month>09</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 Wardhana, Shimizu, Watanabe, Uda and Watarai.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Wardhana, Shimizu, Watanabe, Uda and Watarai</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Background</title>
<p>
<italic>Francisella tularensis</italic> is a highly infectious Gram-negative bacterium that causes tularemia in humans and animals. It has a remarkable ability to survive and replicate within a wide range of host cells. <italic>F. novicida</italic> shares many characteristics with of <italic>F. tularensis</italic>. However, it is rarely pathogenic in humans, and its reduced virulence makes it a suitable model organism for studying <italic>F. tularensis</italic> infection. This study aimed to identify the pathogenic factors of <italic>F. novicida</italic>.</p>
</sec>
<sec>
<title>Methods</title>
<p>Using a novel infection model with HeLa cells expressing Fc&#x3b3;RII (HeLa-Fc&#x3b3;RII cells), we screened 2,232 transposon mutants of <italic>F. novicida</italic> pre-treated with antiserum containing <italic>F. novicida</italic> antibodies to find less cytotoxicity strains. The transposon insertion site was identified by sequencing, leading to the determination of the genes responsible for the attenuated cytotoxicity. Additionally, the intracellular behavior of the mutant was investigated within both HeLa-Fc&#x3b3;RII and THP-1 cells.</p>
</sec>
<sec>
<title>Results and discussion</title>
<p>A total of thirteen mutants with attenuated cytotoxicity were isolated, and their responsible genes were identified. They are <italic>figE, slt, fopA, iglC, igID, iglF, iglI, pdpB, pdpA, ampG</italic>, <italic>wbtF</italic>, and one unnamed gene (FTN_0096). We focused on the <italic>wbtF</italic> gene. The <italic>F. novicida</italic> wild-type (WT) strain showed intracellular replication in HeLa-Fc&#x3b3;RII and THP-1 cells, but the number of intracellular <italic>wbtF</italic> mutants decreased. The <italic>wbtF</italic> mutant could not escape from phagolysosomes in the initial phases of infection and was digested within the lysosome. The <italic>wbtF</italic> mutant was also detected in the mitochondria and the Golgi complex. The cytokine response induced by <italic>wbtF</italic> mutant was comparable to that of the WT strain. These findings indicate that <italic>wbtF</italic> is important for the intracellular replication of <italic>F. novicida</italic>.</p>
</sec>
</abstract>
<kwd-group>
<kwd>
<italic>F. novicida</italic>
</kwd>
<kwd>
<italic>wbtF</italic>
</kwd>
<kwd>cytotoxicity</kwd>
<kwd>intracellular replication</kwd>
<kwd>tularemia</kwd>
</kwd-group>
<contract-num rid="cn001">22K07054, 21H02360</contract-num>
<contract-sponsor id="cn001">Japan Society for the Promotion of Science<named-content content-type="fundref-id">10.13039/501100001691</named-content>
</contract-sponsor>
<counts>
<fig-count count="8"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="71"/>
<page-count count="17"/>
<word-count count="8069"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Bacteria and Host</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>
<italic>Francisella tularensis</italic> is a highly infectious Gram-negative bacterium that causes tularemia, a zoonosis affecting humans and animals. The genus <italic>Francisella</italic> comprises several species including <italic>F. tularensis</italic>, <italic>F. philomiragia</italic>, <italic>F. noatunensis</italic>, <italic>F. hispaniensis</italic> and <italic>F. novicida</italic> (<xref ref-type="bibr" rid="B25">Kingry and Petersen, 2014</xref>; <xref ref-type="bibr" rid="B58">Sjodin et&#xa0;al., 2012</xref>). <italic>F. tularensis</italic> is divided into two main subspecies: Type A (<italic>F. tularensis subsp. tularensis</italic> [<italic>F. tularensis</italic>]) and Type B (<italic>F. tularensis subsp. holarctica</italic> [<italic>F. holarctica</italic>]). Type A is considerably more virulent than Type B and is commonly associated with severe disease in humans, whereas Type B typically causes milder illness. Pneumonic tularemia, the most dangerous form, is transmitted through aerosols or inhalation. Remarkably, inhaling as few as 25 colony-forming units (CFUs) may result in pulmonary infection, making <italic>F. tularensis</italic> one of the most infectious bacteria transmitted via the aerosol route (<xref ref-type="bibr" rid="B23">Harrell et&#xa0;al., 2024</xref>). <italic>Francisella</italic> is a significant pathogen associated with high morbidity and mortality rates. The most virulent strain of <italic>Francisella</italic> induces systemic forms of tularemia (pneumonic, typhoidal), with fatality rates reaching 60% (<xref ref-type="bibr" rid="B70">Yeni et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B65">Wawszczak et&#xa0;al., 2022</xref>). Due to its high infectivity and potential for airborne spread, <italic>F. tularensis</italic> has been developed and stockpiled as a biological warfare agent by several nations (<xref ref-type="bibr" rid="B15">Dennis et&#xa0;al., 2001</xref>).</p>
<p>
<italic>F. novicida</italic> is classified as a separate species from <italic>F. tularensis</italic>, but due to the high genomic homology, it is sometimes classified as a subspecies of <italic>F. tularensis</italic> (<xref ref-type="bibr" rid="B24">Johansson et&#xa0;al., 2010</xref>). Because <italic>Francisella novicida</italic> (<italic>F. novicida</italic>) is considerably less virulent than <italic>F. tularensis</italic>, it is commonly used as a surrogate strain for virulent <italic>F. tularensis</italic>. In contrast to <italic>F. tularensis</italic>, <italic>F. novicida</italic> is an opportunistic pathogen that causes illness and even death in debilitated or immunocompromised patients but not in healthy individuals. Due to the rarity of <italic>F. novicida</italic> infections, effective detection is challenging (<xref ref-type="bibr" rid="B6">Brett et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B25">Kingry and Petersen, 2014</xref>). <italic>F. novicida</italic> shares many characteristics with Type A strains of <italic>F. tularensis</italic>, showing similarities in the genome sequence, intracellular life cycle, and mechanisms of infectivity, including rapid phagosomal escape followed by vigorous cytosolic replication. It also infects macrophages, causing disease in mice. However, due to its lower virulence in humans, it can be safely handled under Biosafety Level 2 laboratory conditions (<xref ref-type="bibr" rid="B25">Kingry and Petersen, 2014</xref>; <xref ref-type="bibr" rid="B34">Marecic et&#xa0;al., 2017</xref>). <italic>F. novicida</italic> strain U112 possesses a potent tool in the form of a specific transposon mutant, which has been used to investigate the intracellular life cycle of <italic>Francisella</italic> and elucidate its virulence mechanisms (<xref ref-type="bibr" rid="B66">Weiss et&#xa0;al., 2007</xref>; <xref ref-type="bibr" rid="B18">Gallagher et&#xa0;al., 2007</xref>).</p>
<p>Typically, nonpathogenic bacteria taken up by host cells are enclosed in vacuoles or phagosomes, which mature through the endocytic pathway and ultimately fuse with lysosomes, leading to bacterial degradation. Intracellular pathogens have evolved strategies to evade this process within phagocytic cells and resist phagosome&#x2013;lysosome fusion (<xref ref-type="bibr" rid="B51">Ray et&#xa0;al., 2009</xref>). In particular, <italic>Francisella</italic> species exhibit a complex intracellular life cycle and notable environmental persistence (<xref ref-type="bibr" rid="B55">Rowe and Huntley, 2015</xref>). Their survival and replication rely heavily on escaping the initial phagosomal compartment and replicating within the host cell cytosol, making <italic>Francisella</italic> a model cytosolic pathogen. The ability to persist and multiply inside phagocytes and other host cells is fundamental to its pathogenicity. Disruptions in key mechanisms, such as receptor engagement, resistance to reactive oxygen species (ROS), phagosomal escape, cytosolic replication, and evasion of innate immune recognition, significantly impair <italic>F. tularensis</italic> survival and reduce its virulence in both <italic>in vitro</italic> and <italic>in vivo</italic> models (<xref ref-type="bibr" rid="B9">Celli and Zahrt, 2013</xref>).</p>
<p>
<italic>wbtF</italic> is assigned as a potential NAD-dependent epimerase and UDP-glucose 4 epimerase (UGE) (<xref ref-type="bibr" rid="B64">Thomas et&#xa0;al., 2007</xref>). It shows sequence similarity with established UGEs, including wbpP from <italic>Pseudomonas aeruginosa</italic> (<xref ref-type="bibr" rid="B49">Prior et&#xa0;al., 2003</xref>). wbpP is necessary for producing UDP-N-acetyl-D-galacturonic acid, a precursor to the galactosaminuronic acid-derived components of the O-antigen (<xref ref-type="bibr" rid="B37">Miller et&#xa0;al., 2008</xref>). UGE, part of the short-chain dehydrogenase/reductase enzyme superfamily, catalyzes the final step in the interconversion of UDP-glucose and UDP-galactose during galactose metabolism in bacteria and mammals (<xref ref-type="bibr" rid="B17">Fushinobu, 2021</xref>). <xref ref-type="bibr" rid="B64">Thomas et&#xa0;al. (2007)</xref> identified <italic>wbtF</italic> genes as a virulence determinant of <italic>F. tularensis</italic>, but its function remains unknown.</p>
<p>In this study, we created a transposon mutant library of <italic>F. novicida</italic> and screened for infection using epithelial cells, HeLa cells expressing the Fc&#x3b3;RII (HeLa-Fc&#x3b3;RII cells) (<xref ref-type="bibr" rid="B42">Nakamura et&#xa0;al., 2024</xref>). We focused our investigation on <italic>wbtF</italic> and analyzed that the <italic>wbtF</italic> was associated with the intracellular replication of <italic>F. novicida</italic>.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<label>2</label>
<title>Materials and methods</title>
<sec id="s2_1">
<label>2.1</label>
<title>Bacterial strains and culture conditions</title>
<p>
<italic>F. novicida</italic> U112 was obtained from the Pathogenic Microorganism Genetic Resource Stock Center (Gifu University) and cultured aerobically at 37&#xb0;C in a chemically defined medium (CDM) (<xref ref-type="bibr" rid="B39">Nagle et&#xa0;al., 1960</xref>) or on brain&#x2013;heart infusion broth enriched with cysteine (BHIc) (<xref ref-type="bibr" rid="B35">McGann et&#xa0;al., 2010</xref>) and solidified with 1.5% agar (Wako Laboratory Chemicals, Osaka, Japan).</p>
</sec>
<sec id="s2_2">
<label>2.2</label>
<title>Cell culture conditions</title>
<p>HeLa cells were maintained in Dulbecco&#x2019;s Modified Eagle Medium (DMEM; Sigma-Aldrich, St. Louis, MO, USA) supplemented with 10% heat-inactivated fetal bovine serum (FBS; Thermo Fisher, Waltham, MA, USA). The cultures were incubated at 37&#xb0;C in a humidified atmosphere containing 5% CO<sub>2</sub>. Similarly, the human monocytic cell line THP-1 was cultured under the same incubation conditions in RPMI 1640 medium (Sigma-Aldrich, St. Louis, MO) supplemented with 10% heat-inactivated FBS.</p>
</sec>
<sec id="s2_3">
<label>2.3</label>
<title>Transposon mutant library construction</title>
<p>A transposon mutant library was constructed using the Ez-Tn5 Transposome system (Epicentre, Madison, WI, USA). The multiple cloning sites of plasmid pMOD3 were digested with <italic>Hin</italic>dIII and <italic>Eco</italic>RI to construct the transposon. A kanamycin resistance cassette from pKEK1140 (<xref ref-type="bibr" rid="B54">Rodriguez et&#xa0;al., 2008</xref>) was inserted into these sites, creating the plasmid pMOD3-FtKm. The transposon region of pMOD3-FtKm was amplified by polymerase chain reaction, purified, and combined with transposase according to the manufacturer&#x2019;s instructions. This transposon mixture was introduced into <italic>F. novicida</italic> by cryotransformation. Following transformation, the bacteria were plated on BHIc agar supplemented with 50 &#x3bc;g/mL kanamycin to select for mutants.</p>
</sec>
<sec id="s2_4">
<label>2.4</label>
<title>Cytotoxicity assay</title>
<p>HeLa-Fc&#x3b3;RII cells (5 &#xd7; 10<sup>4</sup> cells/well) were seeded in 48-well tissue culture plates and incubated for 24 h. <italic>F. novicida</italic> strains preincubated with mouse serum containing anti-<italic>F. novicida</italic> antibodies were added at a multiplicity of infection (MOI) of 1. The plates were centrifuged at 300 &#xd7;<italic>g</italic> at room temperature for 10 min to promote bacterial contact with the cells and then incubated at 37&#xb0;C for the designated times. Following incubation, the cells were washed three times with DMEM to remove nonadherent bacteria and treated with gentamicin (50 &#x3bc;g/mL) for 1 h to eliminate extracellular bacteria. Infected cells were monitored microscopically at designated time intervals to assess the relative cytotoxicity of the transposon mutant library. To evaluate cytotoxicity, lactate dehydrogenase (LDH) release was measured after incubating cells in DMEM at 37&#xb0;C for a defined period. LDH levels in the culture supernatant were then quantified using the LDH Cytotoxicity Detection Kit (Takara Bio, Shiga, Japan). In brief, cell culture supernatants were collected and incubated with the catalyst and dye solutions for 30 min at room temperature in the dark. Absorbance was measured at 490 nm with a reference wavelength of 600 nm using a microplate reader. LDH activity was expressed as a percentage of total LDH release, determined from lysed cell controls.</p>
</sec>
<sec id="s2_5">
<label>2.5</label>
<title>Sequence analysis of transposon mutants</title>
<p>The plasmid pMOD3 carries the R6K&#x3b3; origin of replication, facilitating propagation in <italic>Escherichia coli</italic>. Genomic DNA from <italic>F. novicida</italic> transposon mutants was extracted using a PureLink Genomic DNA Mini Kit (Thermo Fisher) and digested with restriction enzymes (<italic>Xho</italic>I, <italic>Bgl</italic>II, <italic>Eco</italic>RI, <italic>Sal</italic>I, <italic>Not</italic>I, <italic>Bam</italic>HI, <italic>Pst</italic>I, and <italic>Sph</italic>I). The resultant DNA fragments were blunted using a DNA Blunting Kit (Takara Bio) and then ligated using Ligation High Ver. 2 (Toyobo). The ligation products were introduced into One Shot PIR1 Chemically Competent <italic>E. coli</italic> (Thermo Fisher) via transformation. Kanamycin-resistant colonies were selected, and plasmid DNA was isolated. Sequencing was performed using the primers specified in the Ez-Tn5 Transposome system manual to determine transposon insertion sites.</p>
</sec>
<sec id="s2_6">
<label>2.6</label>
<title>Green fluorescent protein&#x2013;expression by <italic>F</italic>. <italic>novicida</italic> and complementary strains</title>
<p>GFP-expressing plasmids (pOM5-GFP) were generated as described by <xref ref-type="bibr" rid="B56">Shimizu et&#xa0;al. (2019)</xref>. Briefly, the plasmids were introduced into the wild-type (WT) and <italic>wbtF</italic> mutant strains of <italic>F. novicida</italic> via electroporation. To create pOM5-wbtF or complementary strains, <italic>wbtF</italic> of <italic>F. novicida</italic>, along with its native promoter region (300 bp upstream), was cloned into the pOM5 vector. The resultant plasmid (pOM5-wbtF) was used to transform the <italic>wbtF</italic> mutant strains of <italic>F. novicida</italic> via electroporation for complementation studies.</p>
</sec>
<sec id="s2_7">
<label>2.7</label>
<title>Intracellular replication assay</title>
<p>THP-1 cells (4 &#xd7; 10<sup>5</sup> cells/well) were seeded in 24-well tissue culture plates and differentiated by treatment with 200 nM phorbol 12-myristate 13-acetate (PMA) for 48 h. HeLa-Fc&#x3b3;RII cells (1 &#xd7; 10<sup>5</sup> cells/well) were cultured overnight on 12-mm glass coverslips placed in 24-well plates. <italic>F. novicida</italic> strains were added to the THP-1 cells and <italic>F. novicida</italic> strains were opsonized with mouse serum added to the HeLa-Fc&#x3b3;RII cells at an MOI of 1. After infection, the THP-1 and HeLa-Fc&#x3b3;RII cells were washed three times with RPMI 1640 medium and DMEM, respectively. To remove extracellular bacteria, all wells were treated with gentamicin (50 &#x3bc;g/mL) for 1 h. Then, the cells were incubated in fresh medium at 37&#xb0;C for the designated times. To analyze intracellular replication, infected cells were washed with phosphate-buffered saline and lysed using 0.1% Triton X-100 in chemically defined medium (CDM). The lysates underwent serial dilution and were plated on BHIc agar to determine the number of CFUs.</p>
</sec>
<sec id="s2_8">
<label>2.8</label>
<title>Fluorescence microscopy</title>
<p>THP-1 cells (4 &#xd7; 10<sup>5</sup> cells/well) were seeded on 12-mm glass coverslips in 24-well tissue culture plates and differentiated with 100 nM phorbol 12-myristate 13-acetate (PMA) for 48 h. HeLa-Fc&#x3b3;RII cells (1 &#xd7; 10<sup>5</sup> cells/well) were cultured overnight on 12-mm glass coverslips placed in 24-well plates. The THP-1 cells were infected with GFP-expressing <italic>F. novicida</italic> strains and incubated for the designated times. For HeLa-Fc&#x3b3;RII cells, GFP-expressing <italic>F. novicida</italic> strains were preincubated with mouse serum and added at an MOI of 1, followed by incubation for the designated times. The cells were stained with LysoTracker Red DND-99, MitoTracker Deep Red FM, and BODIPY TR Ceramide (Thermo Fisher) to visualize lysosomes, mitochondria, and the Golgi complex, respectively. To detect lysosomal-associated membrane protein 1 (LAMP-1), cells were fixed using a PLP Solution Set (FUJIFILM Wako Chemicals) containing 5% sucrose for 1 h at 37&#xb0;C and then permeabilized using ice-cold methanol for 10 s. The fixed cells were incubated with anti-LAMP-1 antibody (ab25245, 1:100; Abcam), followed by staining with TRITC-conjugated anti-rat IgG secondary antibody (ab150158, 1:1000; Abcam). Confocal images were captured using a FluoView FV1000 laser scanning microscope (Olympus, Tokyo, Japan).</p>
</sec>
<sec id="s2_9">
<label>2.9</label>
<title>ELISA</title>
<p>THP-1 cells (4 &#xd7; 10<sup>5</sup> cells per well) were seeded into a 48-well culture plate and treated with 100 nM PMA for 48 hours. Following this, they were infected with <italic>F. novicida</italic> strains, including the <italic>wbtF</italic> mutant and its complementary strains. After 2, 6, 12, and 24 h of incubation, the levels of tumor necrosis factor (TNF)-&#x3b1; and interleukin (IL)-6 in the culture supernatants were quantified using the ELISA MAX Standard Kit (Biolegend, San Diego, CA), following the manufacturer&#x2019;s protocol.</p>
</sec>
<sec id="s2_10">
<label>2.10</label>
<title>Statistical analysis</title>
<p>Differences between groups were evaluated using Welch&#x2019;s <italic>t</italic>-test or multiple comparison tests, including the Bonferroni and Dunnett methods, as appropriate. Before these analyses, data normality was assessed using the Shapiro&#x2013;Wilk test. <italic>P</italic> &lt; 0.01 was considered statistically significant.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<label>3</label>
<title>Results</title>
<sec id="s3_1">
<label>3.1</label>
<title>Thirteen genes in the <italic>F. novicida</italic> transposon mutant library showed less cytotoxicity to HeLa-Fc&#x3b3;RII cells</title>
<p>We constructed an <italic>F. novicida</italic> transposon mutant library to identify the virulence factors of <italic>F. novicida</italic>. We previously developed a novel infection model of <italic>Francisella</italic> using HeLa cells expressing mouse Fc&#x3b3;RII (HeLa-Fc&#x3b3;RII) cells (<xref ref-type="bibr" rid="B42">Nakamura et&#xa0;al., 2024</xref>). In this cell line, cellular uptake occurs via antibodies and Fc&#x3b3;RII. Therefore, it was expected that screening with this cell line would allow us to identify novel virulence factors crucial for pathogenesis after cellular uptake. We screened the <italic>F. novicida</italic> transposon mutant library using HeLa-Fc&#x3b3;RII cells. <italic>F. novicida</italic> exhibits cytotoxicity toward epithelial cells, including HeLa-Fc&#x3b3;RII cells, leading to cell death. We microscopically screened the transposon mutant library for strains lacking cytotoxic activity to identify genes associated with this cytotoxic effect. Of the 2,232 transposon mutants screened, 13 were identified as less cytotoxic. Significant differences in host cell condition were evident, while wild-type infection caused pronounced disruption and cell loss, monolayers exposed to the 13 mutants retained their structure and remained largely intact. To confirm these results, LDH assays were performed. The mutant strains caused less LDH release from HeLa-Fc&#x3b3;RII cells than the WT strain, indicating reduced cytotoxicity (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>). The insertion sites in these mutant strains were sequenced to determine the disrupted genes (<xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>). We focused on mutants with the code number G7-7, which encode <italic>wbtF</italic>, and analyzed the gene function.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>HeLa-Fc&#x3b3;RII cells were infected with transposon mutants of <italic>F. novicida</italic> preincubated with mouse serum containing anti-<italic>F. novicida</italic> antibodies at an MOI of 1 and incubated at 37&#xb0;C for 24 h. LDH release was measured as an indicator of cytotoxicity. The graph presents the mean and standard deviations (SD) of the LDH release at 24 h from three identical experiments. Statistical significance relative to the WT strain was determined using multiple comparisons and is indicated by asterisks. **<italic>P &lt;</italic> 0.01.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1647652-g001.tif">
<alt-text content-type="machine-generated">Bar chart displaying cytotoxicity percentages for various samples labeled WT, A5-6, A11-6, B23-6, C19-4, D3-7, E12-3, F10-3, G7-7, I27-3, I30-6, J9-6, J10-8, J30-2. WT shows the highest cytotoxicity, exceeding fifty percent, while other samples have lower percentages around fifteen to thirty percent. Asterisks indicate statistical significance.</alt-text>
</graphic>
</fig>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Sequence analysis of transposon mutant library.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="center">Strain</th>
<th valign="middle" align="center">Locus_tag</th>
<th valign="middle" align="center">Gene name</th>
<th valign="middle" align="center">Product</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="center">A5-6</td>
<td valign="middle" align="center">FTN_0496</td>
<td valign="middle" align="center">Slt</td>
<td valign="middle" align="center">Soluble lytic transglycosylase</td>
</tr>
<tr>
<td valign="middle" align="center">A11-6</td>
<td valign="middle" align="center">FTN_0756</td>
<td valign="middle" align="center">fopA</td>
<td valign="middle" align="center">Outer membrane protein A</td>
</tr>
<tr>
<td valign="middle" align="center">B23-6</td>
<td valign="middle" align="center">FTN_1641</td>
<td valign="middle" align="center">ampG</td>
<td valign="middle" align="center">peptide-acetyl-coenzyme A transporter family protein</td>
</tr>
<tr>
<td valign="middle" align="center">C19-4</td>
<td valign="middle" align="center">FTN_0496</td>
<td valign="middle" align="center">Slt</td>
<td valign="middle" align="center">Soluble lytic transglycosylase</td>
</tr>
<tr>
<td valign="middle" align="center">D3-7</td>
<td valign="middle" align="center">FTN_1321</td>
<td valign="middle" align="center">IglD</td>
<td valign="middle" align="center">Intracellular growth locus protein D</td>
</tr>
<tr>
<td valign="middle" align="center">E12-3</td>
<td valign="middle" align="center">FTN_0096</td>
<td valign="middle" align="center">&#x2013;</td>
<td valign="middle" align="center">Conserved hypothetical membrane protein</td>
</tr>
<tr>
<td valign="middle" align="center">F10-3</td>
<td valign="middle" align="center">FTN_1309</td>
<td valign="middle" align="center">pdpA</td>
<td valign="middle" align="center">Protein of unknown function</td>
</tr>
<tr>
<td valign="middle" align="center">I27-3</td>
<td valign="middle" align="center">FTN_1686</td>
<td valign="middle" align="center">figE</td>
<td valign="middle" align="center">Hypothetical membrane protein</td>
</tr>
<tr>
<td valign="middle" align="center">G7-7</td>
<td valign="middle" align="center">FTN_1425</td>
<td valign="middle" align="center">wbtF</td>
<td valign="middle" align="center">NAD dependent epimerase</td>
</tr>
<tr>
<td valign="middle" align="center">I30-6</td>
<td valign="middle" align="center">FTN_1322</td>
<td valign="middle" align="center">IglC</td>
<td valign="middle" align="center">Intracellular growth locus protein C</td>
</tr>
<tr>
<td valign="middle" align="center">J9-6</td>
<td valign="middle" align="center">FTN_1313</td>
<td valign="middle" align="center">IglF</td>
<td valign="middle" align="center">Hypotethical protein</td>
</tr>
<tr>
<td valign="middle" align="center">J10-8</td>
<td valign="middle" align="center">FTN_1317</td>
<td valign="middle" align="center">IglI</td>
<td valign="middle" align="center">Protein of unknown function</td>
</tr>
<tr>
<td valign="middle" align="center">J30-2</td>
<td valign="middle" align="center">FTN_1310</td>
<td valign="middle" align="center">pdpB</td>
<td valign="middle" align="center">Protein of unknown function</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s3_2">
<label>3.2</label>
<title>Effect of <italic>wbtF</italic> on intracellular replication in HeLa-Fc&#x3b3;RII cells</title>
<p>To determine the effect of <italic>wbtF</italic> on intracellular replication in HeLa-Fc&#x3b3;RII cells in detail, we infected them with <italic>F</italic>. <italic>novicida</italic> WT and the <italic>wbtF</italic> mutant. Through a fluorescence microscope, we discovered intracellular bacteria using GFP-expressing <italic>F. novicida</italic> strains. We analyzed the intracellular of the WT and <italic>wbtF</italic> mutant 12h and 24h after infection in HeLa-Fc&#x3b3;RII cells (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2A</bold>
</xref>). From 12 to 48 h postinfection, the rate of intracellular replication of the WT strain increased, while that of the <italic>wbtF</italic> mutant decreased (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2B</bold>
</xref>). Complementation of the <italic>wbtF</italic> mutant restored replication to the WT level (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2B</bold>
</xref>). These results suggested <italic>wbtF</italic> involvement in the intracellular replication of <italic>F. novicida</italic> in HeLa-Fc&#x3b3;RII cells.</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>HeLa-Fc&#x3b3;RII cells were infected with <italic>F. novicida</italic> strains preincubated with mouse serum containing anti-<italic>F. novicida</italic> antibodies at an MOI of 1, followed by gentamicin treatment (50 &#x3bc;g/mL) for 1 h <bold>(A)</bold> The infected HeLa-Fc&#x3b3;RII cells were fixed and observed at 12 and 24 h postinfection. Scale bar = 20 &#x3bc;m. <bold>(B)</bold> At 12, 24, and 48 h postinfection, the infected HeLa-Fc&#x3b3;RII cells were lysed with 0.1% Triton X-100, and the lysates were plated on BHIc agar. The graph presents the mean and SD of the number of CFUs at the designated time points from three identical experiments. Statistical significance relative to the WT strain at each designated time point was determined using multiple comparisons and is indicated by asterisks. **<italic>P &lt;</italic> 0.01.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1647652-g002.tif">
<alt-text content-type="machine-generated">Panel A shows two sets of fluorescence microscopy images of bacterial infection in cells for wild type and wbtF mutations at 12 and 24 hours. Green fluorescence indicates bacterial presence, with DIC providing structure context. Panel B presents a line graph comparing bacterial growth (CFU per milliliter) over time post-infection for wild type, wbtF, and wbtF complemented strains. Wild type and complemented strains show increased growth over 48 hours, while wbtF mutant shows significantly lower growth at 12 and 24 hours. Statistical significance is indicated by asterisks.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3_3">
<label>3.3</label>
<title>Role of <italic>wbtF</italic> in avoiding phagolysosomes in HeLa-Fc&#x3b3;RII cells</title>
<p>We studied how the <italic>wbtF</italic> mutant replicates intracellularly in HeLa-Fc&#x3b3;RII cells to clarify the role of <italic>wbtF</italic> in the intracellular replication of <italic>Francisella</italic> and its mechanism of escape from phagolysosomal digestion during the early stages of infection. HeLa-Fc&#x3b3;RII cells were infected with GFP-expressing <italic>F. novicida</italic> strains. At 2 and 6 h postinfection, the cells were stained with LysoTracker and examined using confocal microscopy. The <italic>F. novicida</italic> WT bacteria did not exhibit LysoTracker colocalization. In contrast, the <italic>wbtF</italic> mutant strain exhibited noticeable colocalization with LysoTracker-positive compartments, suggesting defective phagolysosomal evasion (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref>). A low percentage of WT bacteria showed lysosomal colocalization in HeLa-Fc&#x3b3;RII cells. In contrast, a significantly higher percentage of <italic>wbtF</italic> mutant bacteria showed lysosomal colocalization (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>). This suggested that the WT bacteria, but not the <italic>wbtF</italic> mutant bacteria, escaped from the phagolysosomes in HeLa-Fc&#x3b3;RII cells.</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>
<bold>(A)</bold> HeLa-Fc&#x3b3;RII cells were infected with <italic>F. novicida</italic> strains preincubated with mouse serum containing anti-<italic>F. novicida</italic> antibodies at an MOI of 1, followed by gentamicin treatment (50 &#x3bc;g/mL) for 1 h to eliminate extracellular bacteria. The infected HeLa-Fc&#x3b3;RII cells were treated with LysoTracker Red DND-99 to visualize the acidic compartments at 2 and 6 h postinfection. Scale bar = 20 &#x3bc;m. <bold>(B)</bold> Percentage of <italic>F. novicida</italic> colocalization with LysoTracker-labeled lysosomes. Data represent the mean and SD from three identical experiments. Statistical significance relative to the WT strain at each designated time point was determined using Welch&#x2019;s <italic>t</italic>-test and is indicated by asterisks. **<italic>P &lt;</italic> 0.01. <bold>(C)</bold> Percentage of colocalization between <italic>F. novicida</italic> and LAMP-1. Data represent the mean and SD from three identical experiments. Statistical significance relative to the WT strain at each designated time point was determined using Welch&#x2019;s <italic>t</italic>-test and is indicated by asterisks. **<italic>P &lt;</italic> 0.01. <bold>(D)</bold> HeLa-Fc&#x3b3;RII cells were similarly infected then treated with an anti-LAMP-1 antibody and stained with a TRITC-conjugated anti-rat IgG for 2&#x2013;24 h postinfection. Scale bar = 20 &#x3bc;m.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1647652-g003.tif">
<alt-text content-type="machine-generated">Fluorescence microscopy images and bar graphs analyzing bacterial infections over time. Panel A shows wild type and wbtF bacterial localization in lysosomes at two and six hours, with merged red and green stains indicating overlap. Panel B presents a bar graph of lysosome-positive bacteria percentages at two and six hours post-infection for wild type and wbtF, showing significant differences with p&lt;0.01. Panel C features a bar graph of LAMP-1 positive bacteria percentages at two, six, twelve, and twenty-four hours, with similar p-values indicating statistical significance. Panel D exhibits time-lapse fluorescence imaging of LAMP-1 association with bacteria from two to twenty-four hours.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3_4">
<label>3.4</label>
<title>
<italic>F. novicida</italic> escape from lysosomes in HeLa-Fc&#x3b3;RII cells</title>
<p>HeLa-Fc&#x3b3;RII cells were infected with GFP-expressing <italic>F. novicida</italic> WT and <italic>wbtF</italic> mutant strains to determine whether they underwent lysosomal digestion. Lysosomes were visualized using an anti-LAMP-1 antibody (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3D</bold>
</xref>). At 2&#x2013;24 h postinfection, the WT strain replicated intracellularly, with bacterial numbers increasing over time. The <italic>wbtF</italic> mutant showed intracellular replication for up to 12 h postinfection. However, replication was decreased at 24 h postinfection, suggesting impaired long-term survival or replication within the host cells (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3C</bold>
</xref>). Compared with the <italic>wbtF</italic> mutant, a significantly lower percentage of WT strains that infected the HeLa-Fc&#x3b3;RII cells colocalized with LAMP-1 at 2, 6, 12, and 24 h postinfection (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3C</bold>
</xref>). These results indicated that <italic>F</italic>. <italic>novicida</italic> WT escaped lysosomal degradation in the HeLa-Fc&#x3b3;RII cells compared to the <italic>wbtF</italic> mutant, which exhibits reduced escape capacity.</p>
</sec>
<sec id="s3_5">
<label>3.5</label>
<title>Impact of <italic>wbtF</italic> in the mitochondria of HeLa-Fc&#x3b3;RII cells</title>
<p>We infected HeLa-Fc&#x3b3;RII cells with WT and <italic>wbtF</italic> mutant strains to determine the role of <italic>wbtF</italic> in the mitochondria. We visualized the mitochondria using MitoTracker Deep Red FM (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4A</bold>
</xref>) to observe whether the WT and the <italic>wbtF</italic> mutant strains colocalized with the mitochondria. At 2 and 6 h postinfection, a low percentage of the HeLa-Fc&#x3b3;RII cells infected with the WT strain colocalized with the mitochondria (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4B</bold>
</xref>). In contrast, HeLa-Fc&#x3b3;RII cells infected with the <italic>wbtF</italic> mutant showed 61%&#x2013;76% colocalization with the mitochondria (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4B</bold>
</xref>). These results demonstrated that <italic>F</italic>. <italic>novicida</italic> WT effectively modified mitochondrial function and sustained replication, while the <italic>wbtF</italic> mutant could not.</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>HeLa-Fc&#x3b3;RII cells were infected with <italic>F. novicida</italic> strains preincubated with mouse serum containing anti-<italic>F. novicida</italic> antibodies at an MOI of 1, followed by gentamicin treatment (50 &#x3bc;g/mL) for 1 h to eliminate extracellular bacteria. <bold>(A)</bold> The infected HeLa-Fc&#x3b3;RII cells were stained with MitoTracker Deep Red FM at 2 and 6 h postinfection. Scale bar = 20 &#x3bc;m. <bold>(B)</bold> Percentage of <italic>F. novicida</italic> colocalized with the mitochondria. Data represent the mean and SD from three identical experiments. Statistical significance relative to the WT strain at each designated time point was determined using Welch&#x2019;s <italic>t</italic>-test and is indicated by asterisks. **<italic>P &lt;</italic> 0.01. <bold>(C)</bold> Percentage of <italic>F. novicida</italic> colocalized with the Golgi complex. Data represent the mean and SD from three identical experiments. Statistical significance relative to the WT strain at each designated time point was determined using Welch&#x2019;s <italic>t</italic>-test and is indicated by asterisks. **<italic>P &lt;</italic> 0.01. <bold>(D)</bold> The infected HeLa-Fc&#x3b3;RII cells were stained with BODIPY TR ceramide at 2, 6, and 12 h postinfection. Scale bar = 20 &#x3bc;m.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1647652-g004.tif">
<alt-text content-type="machine-generated">Panel A shows fluorescence microscopy images of wild type and wbtF bacteria with mitochondria at 2 and 6 hours, displaying co-localization. Panels B and C present bar charts indicating significant increases in mitochondria and Golgi complex positive bacteria post-infection in wbtF strains. Panel D displays images of wild type and wbtF bacteria with the Golgi complex at 2, 6, and 12 hours, highlighting bacterial localization. Scale bars are present in microscopy images. Statistical significance is marked as p&lt;0.01.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3_6">
<label>3.6</label>
<title>Effect of <italic>wbtF</italic> on the Golgi complex of infected HeLa-Fc&#x3b3;RII cells</title>
<p>We infected HeLa-Fc&#x3b3;RII cells with WT and <italic>wbtF</italic> mutant strains to investigate the function of <italic>wbtF</italic> in the Golgi complex of infected cells. The Golgi complex was stained using BODIPY TR ceramide at 2, 6, and 12 h postinfection. A low percentage of WT bacteria colocalized with the Golgi complex (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4C</bold>
</xref>). In contrast, 57%&#x2013;75% of the <italic>wbtF</italic> mutant bacteria colocalized with the Golgi complex at 2, 6, and 12 h postinfection (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4C</bold>
</xref>). Visualization of intracellular colocalization of the bacteria with the Golgi complex 2, 6, and 12 h postinfection can be seen in <xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4D</bold>
</xref>.</p>
</sec>
<sec id="s3_7">
<label>3.7</label>
<title>Effect of <italic>wbtF</italic> on intracellular replication in THP-1 cells</title>
<p>THP-1 cells were infected with the WT and <italic>wbtF</italic> mutant of <italic>F. novicida</italic> to evaluate the role of <italic>wbtF</italic> in intracellular replication. Fluorescence microscopy using GFP-expressing strains confirmed the presence and localization of intracellular bacteria. Our analysis of the intracellular levels of WT and <italic>wbtF</italic> mutant bacteria at 12, 24, and 48 h postinfection in THP-1 cells further validated the reduced replication capacity of the <italic>wbtF</italic> mutant compared with the WT strain (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5A</bold>
</xref>). The WT strain showed a steady increase in intracellular replication, while the number of <italic>wbtF</italic> mutants was significantly decreased between 12 and 48 h postinfection (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5B</bold>
</xref>). Complementation of the <italic>wbtF</italic> mutant restored replication to the WT level, confirming the role of <italic>wbtF</italic> in intracellular survival (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5B</bold>
</xref>). These findings suggested <italic>wbtF</italic> involvement in <italic>F. novicida</italic> intracellular replication in THP-1 cells.</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>THP-1 cells were infected with <italic>F. novicida</italic> at an MOI of 1, followed by gentamicin treatment (50 &#x3bc;g/mL) for 1 h to eliminate extracellular bacteria. <bold>(A)</bold> The infected THP-1 cells were fixed and observed at 12, 24, and 48 h after infection. Scale bar = 20 &#x3bc;m. <bold>(B)</bold> The infected THP-1 cells were lysed with 0.1% Triton X-100 at 12, 24, and 48 h postinfection, and the lysates were plated on BHIc agar. Data represent the mean and SD from three identical experiments. Statistical significance relative to the WT strain at each designated time point was determined using multiple comparisons and is indicated by asterisks. **<italic>P &lt;</italic> 0.01.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1647652-g005.tif">
<alt-text content-type="machine-generated">Panel A shows fluorescence microscopy images of cells infected for 12, 24, and 48 hours. The columns display Wild Type, DIC, and Merge images, with green fluorescence indicating bacterial presence. Panel B is a line graph showing bacterial growth over time as colony-forming units per milliliter for Wild Type, WbtF, and wbtF/wbtF, with statistical significance marked for certain time points.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3_8">
<label>3.8</label>
<title>Role of <italic>wbtF</italic> in avoiding phagolysosomes in THP-1 cells</title>
<p>We infected THP-1 cells with GFP-expressing <italic>F. novicida</italic> strains to investigate the role of <italic>wbtF</italic> in intracellular survival, specifically its involvement in phagolysosomal escape. We assessed the ability of <italic>F. novicida</italic> to evade phagolysosomal fusion during the initial stage of infection (2 and 6 h postinfection) using LysoTracker staining visualized under confocal microscopy. <italic>F. novicida</italic> WT showed low levels of colocalization with LysoTracker, indicating efficient evasion of phagolysosomal fusion. In contrast, the <italic>wbtF</italic> mutant colocalized with LysoTracker-positive lysosomes (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6A</bold>
</xref>). Only a limited number of WT bacteria were colocalized with the lysosomes, while a significantly higher number of <italic>wbtF</italic> mutant bacteria were detected within the lysosomal compartments (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6B</bold>
</xref>). This suggested that the WT strain escaped from the phagolysosomes in THP-1 cells, but the <italic>wbtF</italic> mutant could not.</p>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>THP-1 cells were infected with <italic>F. novicida</italic> strains at an MOI of 1, followed by gentamicin treatment (50 &#x3bc;g/mL) for 1 h to eliminate extracellular bacteria. <bold>(A)</bold> The infected THP-1 cells were treated with LysoTracker Red DND-99 for 2&#x2013;6 h postinfection. Scale bar = 20 &#x3bc;m. <bold>(B)</bold> Percentage of <italic>F. novicida</italic> colocalized with lysosomes. Data represent the mean and SD from three identical experiments. Statistical significance relative to the WT strain at each designated time point was determined using Welch&#x2019;s <italic>t</italic>-test and is indicated by asterisks. **<italic>P &lt;</italic> 0.01. <bold>(C)</bold> Percentage of <italic>F. novicida</italic> colocalized with LAMP-1. Data represent the mean and SD from three identical experiments. Statistical significance relative to the WT strain at each designated time point was determined using Welch&#x2019;s <italic>t</italic>-test and is indicated by asterisks. **<italic>P &lt;</italic> 0.01. <bold>(D)</bold> The infected THP-1 cells were treated with anti-LAMP-1 antibody and stained with TRITC-conjugated anti-rat IgG for 2&#x2013;24 h postinfection. Scale bar = 20 &#x3bc;m.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1647652-g006.tif">
<alt-text content-type="machine-generated">Image displaying scientific data on bacteria-intracellular trafficking. Panel A shows fluorescence microscopy images of wild-type and WbtF mutant bacteria in lysosomes at 2 and 6 hours post-infection. Panels B and C feature bar graphs comparing lysosome and LAMP-1 positive bacteria percentages over time, with wild-type and WbtF strains. Panel D presents fluorescence images of interactions with LAMP-1 over 2, 6, 12, and 24 hours, highlighting differences between wild-type and WbtF.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3_9">
<label>3.9</label>
<title>
<italic>F. novicida</italic> escape from lysosomes in THP-1 cells</title>
<p>THP-1 cells were infected with the GFP-expressing <italic>F. novicida</italic> WT and <italic>wbtF</italic> mutant strains to investigate whether lysosomes contributed to <italic>F. novicida</italic> degradation. Lysosomes were visualized using an anti-LAMP-1 antibody (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6D</bold>
</xref>). The WT strain exhibited consistent intracellular replication at 2&#x2013;24 h postinfection, as indicated by the increasing number of bacteria. In contrast, the <italic>wbtF</italic> mutant replicated up to 12 h postinfection, but the intracellular bacterial load declined markedly by 24 h postinfection. Compared with the <italic>wbtF</italic> mutant, a significantly lower percentage of WT strains colocalized with LAMP-1 at 2, 6, 12, and 24 h postinfection (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6C</bold>
</xref>). These results indicated that <italic>F</italic>. <italic>novicida</italic> WT escaped lysosomal degradation in the THP-1 cells, whereas the <italic>wbtF</italic> mutant could not.</p>
</sec>
<sec id="s3_10">
<label>3.10</label>
<title>Impact of <italic>wbtF</italic> in the mitochondria of THP-1 cells</title>
<p>THP-1 cells were infected with WT and <italic>wbtF</italic> mutant strains to determine the role of <italic>wbtF</italic> in the mitochondria. We visualized the mitochondria using MitoTracker Deep Red FM (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7A</bold>
</xref>) to observe whether the WT and the <italic>wbtF</italic> mutant bacteria colocalized with the mitochondria. A low percentage of the WT bacteria colocalized with the mitochondria (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7B</bold>
</xref>). In contrast, 69%&#x2013;78% of the <italic>wbtF</italic> mutant bacteria colocalized with the mitochondria at 2 and 6 h postinfection (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7B</bold>
</xref>). These results indicated that <italic>F</italic>. <italic>novicida</italic> WT modified mitochondrial function and sustained replication in the THP-1 cells, while the <italic>wbtF</italic> mutant could not.</p>
<fig id="f7" position="float">
<label>Figure&#xa0;7</label>
<caption>
<p>THP-1 cells were infected with <italic>F. novicida</italic> at an MOI of 1, followed by gentamicin treatment (50 &#x3bc;g/mL) for 1 h to eliminate extracellular bacteria. <bold>(A)</bold> The infected THP-1 cells were treated with MitoTracker Deep Red FM at 2 and 6 h postinfection. Scale bar = 20 &#x3bc;m. <bold>(B)</bold> Percentage of <italic>F. novicida</italic> colocalized with the mitochondria. Data represent the mean and SD from three identical experiments. Statistical significance relative to the WT strain at each designated time point was determined using Welch&#x2019;s <italic>t</italic>-test and is indicated by asterisks. **<italic>P &lt;</italic> 0.01. <bold>(C)</bold> Percentage of <italic>F. novicida</italic> colocalized with the Golgi complex. Data represent the mean and SD from three identical experiments. Statistical significance relative to the WT strain at each designated time point was determined using Welch&#x2019;s <italic>t</italic>-test and is indicated by asterisks. **<italic>P &lt;</italic> 0.01. <bold>(D)</bold> The infected THP-1 cells were treated with BODIPY TR ceramide at 2, 6, and 12 h after infection. Scale bar = 20 &#x3bc;m.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1647652-g007.tif">
<alt-text content-type="machine-generated">Panel A shows fluorescence microscopy images of wild type and wbtF bacteria in mitochondria at two and six hours post-infection, with green and red fluorescence and merged images. Panel B is a bar chart displaying the percentage of mitochondria-positive bacteria for wild type and wbtF at two and six hours, showing significantly higher percentages for wild type. Panel C is a bar chart showing Golgi complex-positive bacteria percentages at various times, with wild type consistently higher. Panel D presents microscopy images of wild type and wbtF in the Golgi complex at two, six, and twelve hours post-infection with similar fluorescent labeling and merging.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3_11">
<label>3.11</label>
<title>Effect of <italic>wbtF</italic> on the Golgi complex of infected THP-1 cells</title>
<p>We infected THP-1 cells with the WT and <italic>wbtF</italic> mutant strains to analyze the function of <italic>wbtF</italic> in the Golgi complex. The Golgi complex was stained using BODIPY TR ceramide to determine if the Golgi complex could colocalize the WT strain and the <italic>wbtF</italic> mutant. The intracellular bacteria were examined at 2, 6, and 12 h after infection. A low percentage of the WT strain colocalized with the Golgi complex (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7C</bold>
</xref>). In contrast, 61%&#x2013;75% of the <italic>wbtF</italic> mutant bacteria were colocalized with the Golgi complex at 2, 6, and 12 h after infection (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7C</bold>
</xref>). Visualization of intracellular colocalization of the bacteria with the Golgi complex 2, 6, and 12 h postinfection can be seen in <xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7D</bold>
</xref>.</p>
</sec>
<sec id="s3_12">
<label>3.12</label>
<title>Effect of <italic>wbtF</italic> on cytokine production</title>
<p>To evaluate the effect of <italic>wbtF</italic> in cytokine responses, we measured the induction of cytokines produced by THP-1 cells that were infected with WT, <italic>wbtF</italic> mutant and complementary strains. The induction of TNF-&#x3b1; (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8A</bold>
</xref>) and IL-6 (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8B</bold>
</xref>) did not differ significantly among the WT, <italic>wbtF</italic> mutant, and complementary strains.</p>
<fig id="f8" position="float">
<label>Figure&#xa0;8</label>
<caption>
<p>THP-1 cells were infected with <italic>F. novicida</italic> at an MOI of 1, followed by gentamicin treatment (50 &#x3bc;g/mL) for 1 h to eliminate extracellular bacteria. After 2 h, 6 h, 12 h, and 24 h of incubation, cell supernatants were collected, and the levels of TNF-&#x3b1; <bold>(A)</bold> and IL-6 <bold>(B)</bold> were determined using ELISA. The data represent the averages and standard deviations of three identical experiments. Statistical significance relative to the WT strain at each designated time point was determined using multiple comparisons and no significant difference was observed.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1647652-g008.tif">
<alt-text content-type="machine-generated">Bar graphs compare TNF-alpha and IL-6 levels post-infection at 2, 6, 12, and 24 hours for wild type, wbtF, and wbtF/wbtF strains. TNF-alpha levels increase over time, peaking at 24 hours. IL-6 levels also rise, with a similar peak at 24 hours. Each strain follows a consistent pattern. Error bars show variability.</alt-text>
</graphic>
</fig>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<label>4</label>
<title>Discussion</title>
<p>
<italic>Francisella</italic> is a Gram-negative bacterium, and its highly pathogenic species, <italic>F. tularensis</italic>, is a well-known cause of tularemia in humans and other mammals. <italic>F. tularensis</italic> outmaneuvers the host&#x2019;s immune defenses by escaping from the phagosome&#x2014;a cellular structure meant to destroy invaders. Instead of being degraded, the bacteria multiply inside the host cell&#x2019;s cytoplasm, where they are better protected from immune responses (<xref ref-type="bibr" rid="B47">Pavlik et&#xa0;al., 2024</xref>). Scientists are still piecing together the mechanism of phagosomal escape, and a gene cluster called the <italic>Francisella</italic> pathogenicity island (FPI) has emerged as a key player. The FPI encodes component proteins of a unique type VI secretion system thought to be critical to the bacterium&#x2019;s survival and virulence (<xref ref-type="bibr" rid="B11">Clemens et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B53">Rigard et&#xa0;al., 2016</xref>; <xref ref-type="bibr" rid="B59">Spidlova and Stulik, 2017</xref>).</p>
<p>We constructed a transposon mutant library of <italic>F</italic>. <italic>novicida</italic> to isolate mutants that were less cytotoxic. We screened the transposon mutants using a new infection model of <italic>Francisella</italic>, HeLa cells expressing mouse Fc&#x3b3;RII (HeLa-Fc&#x3b3;RII). HeLa-Fc&#x3b3;RII cells are a cell line that expresses the Fc&#x3b3;RII receptor, enabling efficient uptake of IgG-opsonized bacteria (<xref ref-type="bibr" rid="B42">Nakamura et&#xa0;al., 2024</xref>). Although epithelial cells, like HeLa, are readily amenable to genetic modification, infection with <italic>Francisella</italic> is rarely effective and significantly lower than the infection efficiency of macrophage-like cells. <italic>Francisella</italic> infection of epithelial cell lines, such as like HeLa, A549, and HEK293, has been performed at a high MOI (100&#x2013;10,000) and requires a relatively long time (approximately 8&#x2013;24 h) (<xref ref-type="bibr" rid="B29">Lo et&#xa0;al., 2013</xref>; <xref ref-type="bibr" rid="B3">Amer et&#xa0;al., 2010</xref>; <xref ref-type="bibr" rid="B5">Bradburne et&#xa0;al., 2013</xref>). The ability of <italic>Francisella</italic> to infect macrophages largely depends on whether the bacteria are opsonized. The use of unopsonized bacteria leads to rapid disruption of the phagosome. In contrast, opsonizing <italic>Francisella</italic> with fresh serum facilitates directing the bacteria to various phagocytic receptors, resulting in delayed phagosomal escape (<xref ref-type="bibr" rid="B19">Geier and Celli, 2011</xref>). Notably, when HeLa cells engineered to express Fc&#x3b3;RII were infected with antibody-coated bacteria, the infection efficiency was approximately 100 times higher compared with normal HeLa cells (<xref ref-type="bibr" rid="B42">Nakamura et&#xa0;al., 2024</xref>).</p>
<p>Among the 2,232 transposons mutants library, 13 showed less cytotoxicity and were successfully sequenced. Two mutants involved the same gene: FTN_0496 (<italic>slt</italic>). FTN_1686 (<italic>figE</italic>), FTN_0496 (<italic>slt</italic>), FTN_1322 (<italic>IglC</italic>), FTN_1321 (<italic>IglD</italic>), FTN_1309 (<italic>pdpA</italic>), FTN_1310 (<italic>pdpB</italic>), FTN_1317 (<italic>IglI</italic>), FTN_1313 (<italic>IglF</italic>), and FTN_0096 were previously reported as pathogenic factors of <italic>Francisella</italic> (<xref ref-type="bibr" rid="B28">Llewellyn et&#xa0;al., 2011</xref>; <xref ref-type="bibr" rid="B46">Ozanic et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B7">Brodmann et&#xa0;al., 2017</xref>; <xref ref-type="bibr" rid="B48">P&#xe9;rard et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B43">Nakamura et&#xa0;al., 2019</xref>; <xref ref-type="bibr" rid="B13">Dean et&#xa0;al., 2020</xref>). FTN_0756 (<italic>fopA</italic>) and FTN_1641 (<italic>ampG</italic>) were previously reported as immunosuppressive factors involved in dampening host immune responses (<xref ref-type="bibr" rid="B40">Nakamura et&#xa0;al., 2022</xref>). However, this was the first report of FTN_1425 (<italic>wbtF</italic>). Therefore, we focused on <italic>wbtF</italic>. Although <italic>wbtF</italic> has been reported as a non-essential gene that can be disrupted (<xref ref-type="bibr" rid="B64">Thomas et&#xa0;al., 2007</xref>), we were unable remove the gene using a suicide vector (<xref ref-type="bibr" rid="B43">Nakamura et&#xa0;al., 2019</xref>) in this study. Therefore, we attempted to directly investigate <italic>wbtF</italic> gene from a transposon mutant library of <italic>F. novicida</italic>.</p>
<p>
<italic>wbtF</italic> is one of the O-antigen biosynthetic gene clusters of <italic>F. tularensis</italic> (<xref ref-type="bibr" rid="B12">Clemens et&#xa0;al., 2012</xref>). The O-antigen capsule in <italic>Francisella</italic> comprises a polysaccharide that is structurally identical to the O-antigen found in lipopolysaccharide (LPS). This LPS O-antigen is a critical pathogenic factor. O-antigen deficiency results in increased sensitivity to serum and a loss of virulence in Type A and B strains of <italic>F. tularensis</italic> (<xref ref-type="bibr" rid="B8">Catanzaro and Inzana, 2020</xref>). <xref ref-type="bibr" rid="B64">Thomas et&#xa0;al. (2007)</xref> created knock-out mutants targeting the O-antigen gene cluster in <italic>F. novicida</italic> and <italic>F. tularensis</italic> SchuS4, leading to the complete loss of O-antigen production. Notably, the SchuS4 mutant lacking the O-antigen was fully attenuated in mice.</p>
<p>
<italic>Francisella</italic> species are highly pathogenic, largely due to their ability to replicate within the cytosol of phagocytic cells, such as macrophages and dendritic cells. After entering these cells through phagocytosis, the bacteria are initially enclosed within a membrane-bound compartment called the <italic>Francisella</italic>-containing phagosome. However, they rapidly disrupt the phagosomal membrane and escape into the host cell cytosol, where they replicate. The bacteria adapt their metabolism to the cytosolic environment by relying on gluconeogenesis and amino acid catabolism as carbon and energy sources. Thus, phagosomal escape is critical for <italic>Francisella</italic>&#x2019;s ability to replicate inside host cells, leading to disease <italic>in vivo</italic>. Phagosomal escape also triggers the host&#x2019;s antimicrobial and innate immune defenses. In many cases, once the infected cell becomes overloaded with bacteria and dies, the bacteria exit and potentially spread to neighboring cells (<xref ref-type="bibr" rid="B14">Degabriel et&#xa0;al., 2023</xref>; <xref ref-type="bibr" rid="B10">Chong and Celli, 2010</xref>).</p>
<p>In this research, intracellular replication of the <italic>F. novicida</italic> WT strain in HeLa-Fc&#x3b3;RII cells and THP-1 cells increased at 12&#x2013;48 h after infection. This correlated with previous findings of increased intracellular replication of <italic>Francisella</italic> WT in HeLa-Fc&#x3b3;RII and THP-1 cells (<xref ref-type="bibr" rid="B41">Nakamura et&#xa0;al., 2021</xref>, <xref ref-type="bibr" rid="B42">2024</xref>). Compared with the WT strain, the <italic>wbtF</italic> mutant underwent intracellular replication for up to 12 h after infection in HeLa-Fc&#x3b3;RII and THP-1 cells, but then decreased at 24 and 48 h after infection. The rate of intracellular replication of the <italic>wbtF</italic> mutant was significantly lower than that of the WT strain (<italic>P &lt;</italic>0.01). <xref ref-type="bibr" rid="B64">Thomas et&#xa0;al. (2007)</xref> demonstrated that the O-antigen of <italic>F. tularensis</italic> was essential for the survival and replication inside host cells.</p>
<p>The acidic organelles were stained with LysoTracker. The <italic>wbtF</italic> mutant bacteria showed colocalization with LysoTracker in the early stages of infection (2&#x2013;6 h) of HeLa-Fc&#x3b3;RII cells (60%&#x2013;71%) and THP-1 cells (72%&#x2013;74%). Furthermore, the <italic>wbtF</italic> mutant also colocalized with the lysosome marker LAMP-1 at 2, 6, 12, and 48 h postinfection in 78%&#x2013;88% of HeLa-Fc&#x3b3;RII cells and 71%&#x2013;82% of THP-1 cells.</p>
<p>
<italic>F. tularensis</italic> virulence is closely associated with its ability to survive inside phagocytic cells and escape into the cytosol. Upon host cell entry, the bacterium is initially enclosed in a phagosome that typically matures into a phagolysosome. However, <italic>F. tularensis</italic> disrupts this maturation by blocking fusion between the phagosome and lysosome. Then, it breaks down the phagosomal membrane and escapes into the cytoplasm, where it replicates. The molecular mechanism underlying the phagosomal escape of <italic>Francisella</italic> remains poorly understood. However, it has been shown that disrupting genes within the FPI prevents the bacterium from phagosomal escape (<xref ref-type="bibr" rid="B59">Spidlova and Stulik, 2017</xref>). Thus, our findings suggest that the <italic>wbtF</italic> mutant could not escape from the phagosomes, indicating that <italic>wbtF</italic> is required for intracellular replication of <italic>F</italic>. <italic>novicida</italic>.</p>
<p>Mitochondria are double-membraned organelles vital for various cellular processes and cell survival. Their metabolic functions are crucial for maintaining tissue balance across different cell types and organisms. Unsurprisingly, these metabolic pathways often shift in response to stressors, like nutrient deprivation. Beyond their role in energy production, mitochondria are also highly involved in regulating cell death during infection and have been increasingly recognized as important hubs for immune signaling (<xref ref-type="bibr" rid="B60">Spinelli and Haigis, 2018</xref>; <xref ref-type="bibr" rid="B38">Mills et&#xa0;al., 2017</xref>). We observed that the <italic>F. novicida</italic> WT strain associates with mitochondria in HeLa&#x2013;Fc&#x3b3;RII cells and THP-1 cells, and underwent intracellular replication. Furthermore, it did not colocalize with mitochondria (MitoTracker) at 2&#x2013;6 h after infection. In contrast, the <italic>wbtF</italic> mutant colocalized with the mitochondria during the initial stages of infection (2&#x2013;6 h) in HeLa-Fc&#x3b3;RII cells (61%&#x2013;76%) and THP-1 cells (69%&#x2013;78%).</p>
<p>Mitochondria are highly susceptible to damage, and their dysfunction disrupts cellular homeostasis. Such disturbances are closely linked to the development of various diseases, including neurodegenerative and cardiovascular conditions, cancer, metabolic disorders, and infections. Thus, the impaired mitochondria must be promptly isolated and selectively eliminated. Mitophagy (mitochondrial autophagy) is a critical cellular process that eliminates damaged mitochondria, thereby preserving mitochondrial and overall cellular homeostasis. When cells are exposed to stressors such as ROS, nutrient scarcity, or aging, mitochondria become depolarized and dysfunctional, triggering their selective removal through mitophagy (<xref ref-type="bibr" rid="B16">Doblado et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B45">Onishi et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B68">Xu et&#xa0;al., 2020</xref>; <xref ref-type="bibr" rid="B30">Lu et&#xa0;al., 2023</xref>).</p>
<p>Pathogens stimulate mitophagy to suppress the host defense mechanism. They likely employ a common mechanism that inhibits innate immune responses and promotes persistent infection by directly or indirectly facilitating mitophagy (<xref ref-type="bibr" rid="B31">Ma et&#xa0;al., 2024</xref>). The initiation of mitophagy to eradicate intracellular mitochondrial ROS (mtROS) is an essential survival tactic for intracellular infections. mtROS are essential for innate host defense, functioning as effectors by harming pathogens (<xref ref-type="bibr" rid="B69">Yang et&#xa0;al., 2025</xref>; <xref ref-type="bibr" rid="B57">Silwal et&#xa0;al., 2020</xref>). <xref ref-type="bibr" rid="B2">Alqahtani et&#xa0;al. (2023)</xref> showed that infection with <italic>F. tularensis</italic> live vaccine strain induced mitophagy. Generally, mitophagy is considered to limit the accumulation of mtROS, a significant source of cellular ROS. Microbial pathogens often evade or suppress the host&#x2019;s protective mtROS pathway and neutralize bactericidal free radicals (<xref ref-type="bibr" rid="B62">Su et&#xa0;al., 2023</xref>; <xref ref-type="bibr" rid="B57">Silwal et&#xa0;al., 2020</xref>). Other intracellular bacteria, such as <italic>Staphylococcus aureus</italic>, promote mitophagy to clear mtROS. <italic>S. aureus</italic> not only survives within macrophages but also stimulates mitophagy in host cells to clear mtROS. It uses HDAC11 to augment interleukin 10 (IL-10) transcription, promoting mitophagy to clear mtROS, reduce mitochondrial damage, and maintain an ecological environment favorable for bacterial survival. <italic>Listeria monocytogenes</italic> diminishes mtROS and inhibits cell death by promoting mitophagy through the secretion of its virulence factor, listeriolysin O (<xref ref-type="bibr" rid="B69">Yang et&#xa0;al., 2025</xref>; <xref ref-type="bibr" rid="B71">Zhang et&#xa0;al., 2019</xref>). These findings suggest that the intracellular survival of <italic>Francisella</italic> WT depends on mitochondrial modulation and escape. Indeed, the effector protein <italic>IglJ</italic> has been reported to interact directly with mitochondrial targets (<xref ref-type="bibr" rid="B50">Prok&#x161;ov&#xe1; et&#xa0;al., 2020</xref>). In contrast, the <italic>wbtF</italic> mutant cannot modulate mitochondria and is therefore detected in association with mitochondria. The wbtF gene might be involved in this kind of mitochondrial modulation.</p>
<p>The Golgi complex is a crucial membrane-bound organelle in the perinuclear region that consists of flattened disk-shaped cisternae connected in a ribbon-like structure. It comprises three distinct subcompartments: the <italic>cis-</italic>Golgi, medial-Golgi, and <italic>trans</italic>-Golgi network (<xref ref-type="bibr" rid="B1">Ahat et&#xa0;al., 2019</xref>). The Golgi complex is the modification and sorting hub for proteins and lipids. Newly synthesized proteins and lipids are delivered to the Golgi complex, where they undergo posttranslational modifications and are sorted into vesicles for transport to other organelles or extracellular secretion (<xref ref-type="bibr" rid="B32">Makhoul et&#xa0;al., 2019</xref>).</p>
<p>To explore the activities of the <italic>F. novicida</italic> WT and <italic>wbtF</italic> mutant strains within the Golgi complex, infected HeLa-Fc&#x3b3;RII and THP-1 cells were stained with BODIPY TR ceramide. The <italic>Francisella</italic> WT strain only showed colocalization with the Golgi complex in 2%&#x2013;5% of HeLa-Fc&#x3b3;RII cells and 4%&#x2013;12% of THP-1 cells. However, the <italic>wbtF</italic> mutant was colocalized with the Golgi complex in 57%&#x2013;75% of HeLa-Fc&#x3b3;RII cells and 61%&#x2013;75% of THP-1 cells.</p>
<p>The Golgi complex is a crucial organelle in the host defense systems against intracellular infections. Additionally, recent research indicates that the Golgi complex plays a critical role in immunological signaling (<xref ref-type="bibr" rid="B63">Tao et&#xa0;al., 2020</xref>). Disruption of the structure of the Golgi complex catalyzes the pathogenesis of infectious diseases. Various intracellular bacterial, viral, and protozoan infections trigger Golgi complex destabilization. This evolutionarily conserved strategy enables pathogens to access nutrients, hijack organelle membranes for replication, and subvert host immune defenses (<xref ref-type="bibr" rid="B52">Read et&#xa0;al., 2024</xref>). Type I interferons (IFNs) are induced by the Golgi complex in response to various stimuli, including <italic>Francisella</italic> infection (<xref ref-type="bibr" rid="B20">Gregory et&#xa0;al., 2020</xref>). Type I IFNs are a group of cytokines crucial for shaping innate and adaptive immune responses during viral and bacterial infections. However, they also suppress antibacterial immunity by promoting IL-10 production, inhibiting proinflammatory cytokines and chemokines, and promoting immune cell apoptosis, thereby exacerbating <italic>Francisella</italic> infections (<xref ref-type="bibr" rid="B67">Xia et&#xa0;al., 2025</xref>; <xref ref-type="bibr" rid="B27">Li et&#xa0;al., 2024</xref>). The translocation of the signaling intermediate stimulator of IFN genes (STING, TMEM173) from the endoplasmic reticulum to the <italic>cis</italic>-Golgi is initiated by cyclic GMP-AMP synthase or interferon-&#x3b3; inducible protein 16 following the identification of cytosolic exogenous DNA (<xref ref-type="bibr" rid="B61">Storek et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B36">Meunier et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B33">Man et&#xa0;al., 2015</xref>). STING activates TANK-binding kinase 1 (TBK1) at the Golgi complex by inducing its autophosphorylation at serine 172. Following activation, TBK1 phosphorylates interferon regulatory factor 3, facilitating dimerization and translocation to the nucleus, which drives the expression of immune-related genes, including type I IFNs (<xref ref-type="bibr" rid="B4">Barber, 2011</xref>). Interestingly, structural disruption of the Golgi complex using golgicide A blocks TBK1 phosphorylation in response to <italic>F. tularensis</italic> infection and LPS (<xref ref-type="bibr" rid="B20">Gregory et&#xa0;al., 2020</xref>). These results suggest that <italic>F. novicida</italic> WT escapes from the Golgi complex, but <italic>wbtF</italic>, which was detected in the Golgi complex, cannot escape from the immune response.</p>
<p>Since <italic>wbtF</italic> is a gene involved in O-antigen synthesis, we investigated the cytokine production of the <italic>wbtF</italic> deletion mutant to confirm whether the attenuated cytotoxicity and intracellular proliferation of the mutant were due to the LPS-mediated activation of immune responses. Infection of THP-1 cells with <italic>F. novicida</italic> WT, <italic>wbtF</italic> mutant, and the complemented strain produced similar TNF-&#x3b1; and IL-6 responses, indicating that <italic>wbtF</italic> does not significantly affect cytokine production. The <italic>wbtF</italic> gene, a consecutive gene located within the O-antigen-biosynthetic gene clusters spanning a 17-kb chromosomal region of <italic>F. tularensis</italic>, is directly implicated in LPS biosynthesis. The O-antigen constitutes one of the three components of LPS, along with the lipid A and the oligosaccharide core (<xref ref-type="bibr" rid="B12">Clemens et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B26">Krzy&#x17c;ewska-Dudek et&#xa0;al., 2024</xref>). <italic>Francisella</italic> LPS does not function as an antagonist of TLR4-mediated innate immune signaling in either humans or mice. <italic>Francisella</italic> LPS is tetraacylated, and it elicits only weak activation of TLR4 and demonstrates a markedly reduced ability to induce the secretion of inflammatory cytokines like TNF-&#x3b1; and IL-6 by murine and human innate immune cells (<xref ref-type="bibr" rid="B22">Hajjar et&#xa0;al., 2006</xref>; <xref ref-type="bibr" rid="B21">Gunn and Ernst, 2007</xref>; <xref ref-type="bibr" rid="B44">Noah et&#xa0;al., 2010</xref>). It seems that <italic>Francisella</italic> LPS represents, at most, a minor contributor to the induction of proinflammatory responses within the innate immune system. Although deletion of LPS synthesis genes, such as <italic>kdsA</italic>, have been reported to enhance cytokine production (<xref ref-type="bibr" rid="B40">Nakamura et&#xa0;al., 2022</xref>), the absence of <italic>wbtF</italic> did not impact cytokine production in this study. Taken together, these results imply that the attenuated cytotoxicity and intracellular growth ability observed in <italic>wbtF</italic> deletion mutant are likely due to mechanisms distinct from LPS-mediated immune activation. Although comprehensive understanding of the detailed mechanisms necessitates further investigation, our results may suggest that <italic>wbtF</italic> is important for modulating LPS structure, potentially facilitating the evasion of recognition and uptake by cellular organelles, including phagosomes, mitochondria, and the Golgi apparatus.</p>
<p>In summary, our research focused on identifying a virulence factor of <italic>F. novicida</italic> by screening a transposon mutant library. We used a new infection model of <italic>Francisella</italic> using HeLa cells expressing mouse Fc&#x3b3;RII (HeLa-Fc&#x3b3;RII) (<xref ref-type="bibr" rid="B42">Nakamura et&#xa0;al., 2024</xref>). We identified <italic>wbtF</italic> as a pathogenic factor of <italic>F</italic>. <italic>novicida</italic>. <italic>wbtF</italic> is required for escaping from organelles such as phagosomes, mitochondria, and the Golgi apparatus, followed by intracellular replication in HeLa-Fc&#x3b3;RII and THP-1 cells. Thus, it may be a potential target for controlling <italic>Francisella</italic> infection. However, further research is necessary to elucidate the detailed mechanism of <italic>wbtF</italic> function in <italic>Francisella</italic> infection.</p>
</sec>
</body>
<back>
<sec id="s5" sec-type="data-availability">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/supplementary material. Further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s6" sec-type="author-contributions">
<title>Author contributions</title>
<p>DKW: Data curation, Formal analysis, Resources, Validation, Visualization, Writing &#x2013; original draft. TS: Conceptualization, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Supervision, Validation, Writing &#x2013; review &amp; editing. KW: Investigation, Methodology, Resources, Writing &#x2013; review &amp; editing. AU: Methodology, Resources, Writing &#x2013; review &amp; editing. MW: Conceptualization, Funding acquisition, Project administration, Supervision, Writing &#x2013; review &amp; editing.</p>
</sec>
<sec id="s7" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare financial support was received for the research and/or publication of this article. This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI (Grant Number 22K07054 and 21H02360). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p>
</sec>
<sec id="s8" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s9" sec-type="ai-statement">
<title>Generative AI statement</title>
<p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<sec id="s10" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ahat</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>New insights into the Golgi stacking proteins</article-title>. <source>Front. Cell. Dev. Biol.</source> <volume>7</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcell.2019.00131</pub-id>, PMID: <pub-id pub-id-type="pmid">31380369</pub-id></citation></ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alqahtani</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Miller</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Malik</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Bakshi</surname> <given-names>C. S.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Comparative analysis of absent in melanoma 2-inflammasome activation in <italic>Francisella tularensis</italic> and <italic>Francisella novicida</italic>
</article-title>. <source>Front. Microbiol.</source> <volume>14</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2023.1188112</pub-id>, PMID: <pub-id pub-id-type="pmid">37266012</pub-id></citation></ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amer</surname> <given-names>L. S.</given-names>
</name>
<name>
<surname>Bishop</surname> <given-names>B. M.</given-names>
</name>
<name>
<surname>van Hoek</surname> <given-names>M. L.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Antimicrobial and antibiofilm activity of cathelicidins and short, synthetic peptides against <italic>Francisella</italic>
</article-title>. <source>Biochem. Biophys. Res. Commun.</source> <volume>396</volume>, <fpage>246</fpage>&#x2013;<lpage>251</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bbrc.2010.04.073</pub-id>, PMID: <pub-id pub-id-type="pmid">20399752</pub-id></citation></ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barber</surname> <given-names>G. N.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Innate immune DNA sensing pathways: STING, AIMII and the regulation of interferon production and inflammatory responses</article-title>. <source>Curr. Opin. Immunol.</source> <volume>23</volume>, <fpage>10</fpage>&#x2013;<lpage>20</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.coi.2010.12.015</pub-id>, PMID: <pub-id pub-id-type="pmid">21239155</pub-id></citation></ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bradburne</surname> <given-names>C. E.</given-names>
</name>
<name>
<surname>Verhoeven</surname> <given-names>A. B.</given-names>
</name>
<name>
<surname>Manyam</surname> <given-names>G. C.</given-names>
</name>
<name>
<surname>Chaudhry</surname> <given-names>S. A.</given-names>
</name>
<name>
<surname>Chang</surname> <given-names>E. L.</given-names>
</name>
<name>
<surname>Thach</surname> <given-names>D. C.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Temporal transcriptional response during infection of type II alveolar epithelial cells with <italic>Francisella tularensis</italic> live vaccine strain (LVS) supports a general host suppression and bacterial uptake by macropinocytosis</article-title>. <source>J. Biol. Chem.</source> <volume>288</volume>, <fpage>10780</fpage>&#x2013;<lpage>10791</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M112.362178</pub-id>, PMID: <pub-id pub-id-type="pmid">23322778</pub-id></citation></ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brett</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Doppalapudi</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Respicio-Kingry</surname> <given-names>L. B.</given-names>
</name>
<name>
<surname>Myers</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Husband</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Pollard</surname> <given-names>K.</given-names>
</name>
<etal/>
</person-group>. (<year>2012</year>). <article-title>
<italic>Francisella novicida</italic> bacteremia after a near-drowning accident</article-title>. <source>J. Clin. Microbiol.</source> <volume>50</volume>, <fpage>2826</fpage>&#x2013;<lpage>2829</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/JCM.00995-12</pub-id>, PMID: <pub-id pub-id-type="pmid">22692740</pub-id></citation></ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brodmann</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Dreier</surname> <given-names>R. F.</given-names>
</name>
<name>
<surname>Broz</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Basler</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>
<italic>Francisella</italic> requires dynamic type VI secretion system and ClpB to deliver effectors for phagosomal escape</article-title>. <source>Nat. Commun.</source> <volume>8</volume>, <elocation-id>15853</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ncomms15853</pub-id>, PMID: <pub-id pub-id-type="pmid">28621333</pub-id></citation></ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Catanzaro</surname> <given-names>K. C. F.</given-names>
</name>
<name>
<surname>Inzana</surname> <given-names>T. J.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>The <italic>francisella tularensis</italic> polysaccharides: what is the real capsule</article-title>? <source>MMBR.</source> <volume>84</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/mmbr.00065-19</pub-id>, PMID: <pub-id pub-id-type="pmid">32051235</pub-id></citation></ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Celli</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Zahrt</surname> <given-names>T. C.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Mechanisms of <italic>Francisella tularensis</italic> intracellular pathogenesis</article-title>. <source>Cold Spring Harb. Perspect. Med.</source> <volume>3</volume>, <elocation-id>a010314</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1101/cshperspect.a010314</pub-id>, PMID: <pub-id pub-id-type="pmid">23545572</pub-id></citation></ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chong</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Celli</surname> <given-names>J.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>The <italic>Francisella</italic> intracellular life cycle: toward molecular mechanisms of intracellular survival and proliferation</article-title>. <source>Front. Microbiol.</source> <volume>1</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2010.00138</pub-id>, PMID: <pub-id pub-id-type="pmid">21687806</pub-id></citation></ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clemens</surname> <given-names>D. L.</given-names>
</name>
<name>
<surname>Ge</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>B.-Y.</given-names>
</name>
<name>
<surname>Horwitz</surname> <given-names>M. A.</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>Z. H.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Atomic structure of T6SS reveals interlaced array essential to function</article-title>. <source>Cell.</source> <volume>160</volume>, <fpage>940</fpage>&#x2013;<lpage>951</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cell.2015.02.005</pub-id>, PMID: <pub-id pub-id-type="pmid">25723168</pub-id></citation></ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clemens</surname> <given-names>D. L.</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>B.-Y.</given-names>
</name>
<name>
<surname>Horwitz</surname> <given-names>M. A.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>O-antigen-deficient <italic>Francisella tularensis</italic> live vaccine strain mutants are ingested via an aberrant form of looping phagocytosis and show altered kinetics of intracellular trafficking in human macrophages</article-title>. <source>Infect. Immun.</source> <volume>80</volume>, <fpage>952</fpage>&#x2013;<lpage>967</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.05221-11</pub-id>, PMID: <pub-id pub-id-type="pmid">22202123</pub-id></citation></ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dean</surname> <given-names>S. N.</given-names>
</name>
<name>
<surname>Milton</surname> <given-names>M. E.</given-names>
</name>
<name>
<surname>Cavanagh</surname> <given-names>J.</given-names>
</name>
<name>
<surname>van Hoek</surname> <given-names>M. L.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>
<italic>Francisella novicida</italic> Two-Component System Response Regulator BfpR Modulates iglC Gene Expression, Antimicrobial Peptide Resistance, and Biofilm Production</article-title>. <source>Front. Cell. Infect. Microbiol.</source> <volume>10</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2020.00082</pub-id>, PMID: <pub-id pub-id-type="pmid">32232010</pub-id></citation></ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Degabriel</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Valeva</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Boisset</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Henry</surname> <given-names>T.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Pathogenicity and virulence of <italic>Francisella tularensis</italic>
</article-title>. <source>Virulence.</source> <volume>14</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/21505594.2023.2274638</pub-id>, PMID: <pub-id pub-id-type="pmid">37941380</pub-id></citation></ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dennis</surname> <given-names>D. T.</given-names>
</name>
<name>
<surname>Inglesby</surname> <given-names>T. V.</given-names>
</name>
<name>
<surname>Henderson</surname> <given-names>D. A.</given-names>
</name>
<name>
<surname>Bartlett</surname> <given-names>J. G.</given-names>
</name>
<name>
<surname>Ascher</surname> <given-names>M. S.</given-names>
</name>
<name>
<surname>Eitzen</surname> <given-names>E.</given-names>
</name>
<etal/>
</person-group>. (<year>2001</year>). <article-title>Tularemia as a biological weapon: medical and public health management</article-title>. <source>J. Am. Med. Assoc.</source> <volume>285</volume>, <fpage>2763</fpage>&#x2013;<lpage>2773</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1001/jama.285.21.2763</pub-id>, PMID: <pub-id pub-id-type="pmid">11386933</pub-id></citation></ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Doblado</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Lueck</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Rey</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Samhan-Arias</surname> <given-names>A. K.</given-names>
</name>
<name>
<surname>Prieto</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Stacchiotti</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Mitophagy in human diseases</article-title>. <source>Int. J. Mol. Sci.</source> <volume>22</volume>, <elocation-id>3903</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms22083903</pub-id>, PMID: <pub-id pub-id-type="pmid">33918863</pub-id></citation></ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fushinobu</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Molecular evolution and functional divergence of UDP-hexose 4-epimerases</article-title>. <source>Curr. Opin. Chem. Biol.</source> <volume>61</volume>, <fpage>53</fpage>&#x2013;<lpage>62</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cbpa.2020.09.007</pub-id>, PMID: <pub-id pub-id-type="pmid">33171387</pub-id></citation></ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gallagher</surname> <given-names>L. A.</given-names>
</name>
<name>
<surname>Ramage</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Jacobs</surname> <given-names>M. A.</given-names>
</name>
<name>
<surname>Kaul</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Brittnacher</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Manoil</surname> <given-names>C.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>A comprehensive transposon mutant library of <italic>Francisella novicida</italic>, a bioweapon surrogate</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A</source> <volume>104</volume>, <fpage>1009</fpage>&#x2013;<lpage>1014</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.0606713104</pub-id>, PMID: <pub-id pub-id-type="pmid">17215359</pub-id></citation></ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Geier</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Celli</surname> <given-names>J.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Phagocytic receptors dictate phagosomal escape and intracellular proliferation of Francisella tularensis</article-title>. <source>Infect. Immun.</source> <volume>79</volume>, <fpage>2204</fpage>&#x2013;<lpage>2214</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.01382-10</pub-id>, PMID: <pub-id pub-id-type="pmid">21422184</pub-id></citation></ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gregory</surname> <given-names>D. J.</given-names>
</name>
<name>
<surname>DeLoid</surname> <given-names>G. M.</given-names>
</name>
<name>
<surname>Salmon</surname> <given-names>S. L.</given-names>
</name>
<name>
<surname>Metzger</surname> <given-names>D. W.</given-names>
</name>
<name>
<surname>Kramnik</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Kobzik</surname> <given-names>L.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>SON DNA-binding protein mediates macrophage autophagy and responses to intracellular infection</article-title>. <source>FEBS Lett.</source> <volume>594</volume>, <fpage>2782</fpage>&#x2013;<lpage>2799</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/1873-3468.13851</pub-id>, PMID: <pub-id pub-id-type="pmid">32484234</pub-id></citation></ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gunn</surname> <given-names>J. S.</given-names>
</name>
<name>
<surname>Ernst</surname> <given-names>R. K.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>The structure and function of <italic>Francisella</italic> lipopolysaccharide</article-title>. <source>Ann. N. York. Acad. Sci.</source> <volume>1105</volume>, <fpage>202</fpage>&#x2013;<lpage>218</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1196/annals.1409.006</pub-id>, PMID: <pub-id pub-id-type="pmid">17395723</pub-id></citation></ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hajjar</surname> <given-names>A. M.</given-names>
</name>
<name>
<surname>Harvey</surname> <given-names>M. D.</given-names>
</name>
<name>
<surname>Shaffer</surname> <given-names>S. A.</given-names>
</name>
<name>
<surname>Goodlett</surname> <given-names>D. R.</given-names>
</name>
<name>
<surname>Sj&#xf6;stedt</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Edebro</surname> <given-names>H.</given-names>
</name>
<etal/>
</person-group>. (<year>2006</year>). <article-title>Lack of <italic>in vitro</italic> and <italic>in vivo</italic> recognition of <italic>Francisella tularensis</italic> subspecies lipopolysaccharide by Toll-like receptors</article-title>. <source>Infect. Immun.</source> <volume>74</volume>, <fpage>6730</fpage>&#x2013;<lpage>6738</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.00934-06</pub-id>, PMID: <pub-id pub-id-type="pmid">16982824</pub-id></citation></ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harrell</surname> <given-names>J. E.</given-names>
</name>
<name>
<surname>Roy</surname> <given-names>C. J.</given-names>
</name>
<name>
<surname>Gunn</surname> <given-names>J. S.</given-names>
</name>
<name>
<surname>McLachlan</surname> <given-names>J. B.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Current vaccine strategies and novel approaches to combatting <italic>Francisella</italic> infection</article-title>. <source>Vaccine.</source> <volume>42</volume>, <fpage>2171</fpage>&#x2013;<lpage>2180</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.vaccine.2024.02.086</pub-id>, PMID: <pub-id pub-id-type="pmid">38461051</pub-id></citation></ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Johansson</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Celli</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Conlan</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Elkins</surname> <given-names>K. L.</given-names>
</name>
<name>
<surname>Forsman</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Keim</surname> <given-names>P. S.</given-names>
</name>
<etal/>
</person-group>. (<year>2010</year>). <article-title>Objections to the transfer of <italic>Francisella novicida</italic> to the subspecies rank of <italic>Francisella tularensis</italic>
</article-title>. <source>Int. J. Syst. Evol. Microbiol.</source> <volume>60</volume>, <fpage>1717</fpage>&#x2013;<lpage>1718</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1099/ijs.0.022830-0</pub-id>, PMID: <pub-id pub-id-type="pmid">20688749</pub-id></citation></ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kingry</surname> <given-names>L. C.</given-names>
</name>
<name>
<surname>Petersen</surname> <given-names>J. M.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Comparative review of <italic>Francisella tularensis</italic> and <italic>Francisella novicida</italic>
</article-title>. <source>Front. Cell. Infect. Microbiol.</source> <volume>4</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2014.00035</pub-id>, PMID: <pub-id pub-id-type="pmid">24660164</pub-id></citation></ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krzy&#x17c;ewska-Dudek</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Dulipati</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Kapczy&#x144;ska</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Noszka</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Kotimaa</surname> <given-names>J.</given-names>
</name>
<etal/>
</person-group>. (<year>2024</year>). <article-title>Lipopolysaccharide with long O-antigen is crucial for <italic>Salmonella Enteritidis</italic> to evade complement activity and to facilitate bacterial survival <italic>in vivo</italic> in the <italic>Galleria mellonella</italic> infection model</article-title>. <source>Med. Microbiol. Immunol.</source> <volume>213</volume>, <fpage>8</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00430-024-00790-3</pub-id>, PMID: <pub-id pub-id-type="pmid">38767707</pub-id></citation></ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Yao</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Qian</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Zheng</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2024</year>). <article-title>Inhibition of neutrophil swarming by type I interferon promotes intracellular bacterial evasion</article-title>. <source>Nat. Commun.</source> <volume>15</volume>, <fpage>8663</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41467-024-53060-4</pub-id>, PMID: <pub-id pub-id-type="pmid">39375351</pub-id></citation></ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Llewellyn</surname> <given-names>A. C.</given-names>
</name>
<name>
<surname>Jones</surname> <given-names>C. L.</given-names>
</name>
<name>
<surname>Napier</surname> <given-names>B. A.</given-names>
</name>
<name>
<surname>Bina</surname> <given-names>J. E.</given-names>
</name>
<name>
<surname>Weiss</surname> <given-names>D. S.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Macrophage replication screen identifies a novel <italic>Francisella</italic> hydroperoxide resistance protein involved in virulence</article-title>. <source>PloS One</source> <volume>6</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0024201</pub-id>, PMID: <pub-id pub-id-type="pmid">21915295</pub-id></citation></ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lo</surname> <given-names>K. Y. S.</given-names>
</name>
<name>
<surname>Chua</surname> <given-names>M. D.</given-names>
</name>
<name>
<surname>Abdulla</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Law</surname> <given-names>H. T.</given-names>
</name>
<name>
<surname>Guttman</surname> <given-names>J. A.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Examination of <italic>in vitro</italic> epithelial cell lines as models for <italic>Francisella tularensis</italic> non-phagocytic infections</article-title>. <source>J. Microbiol. Methods</source> <volume>93</volume>, <fpage>153</fpage>&#x2013;<lpage>160</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.mimet.2013.03.004</pub-id>, PMID: <pub-id pub-id-type="pmid">23523968</pub-id></citation></ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>L.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Cellular mitophagy: mechanism, roles in diseases and small molecule pharmacological regulation</article-title>. <source>Theranostics.</source> <volume>13</volume>, <fpage>736</fpage>&#x2013;<lpage>766</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.7150/thno.79876</pub-id>, PMID: <pub-id pub-id-type="pmid">36632220</pub-id></citation></ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Han</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Zhan</surname> <given-names>Y. A.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Mechanism and role of mitophagy in the development of severe infection</article-title>. <source>Cell. Death. Discov.</source> <volume>10</volume>, <fpage>88</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41420-024-01844-4</pub-id>, PMID: <pub-id pub-id-type="pmid">38374038</pub-id></citation></ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Makhoul</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Gosavi</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Gleeson</surname> <given-names>P. A.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Golgi dynamics: the morphology of the mammalian Golgi apparatus in health and disease</article-title>. <source>Front. Cell. Dev. Biol.</source> <volume>7</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcell.2019.00112</pub-id>, PMID: <pub-id pub-id-type="pmid">31334231</pub-id></citation></ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Man</surname> <given-names>S. M.</given-names>
</name>
<name>
<surname>Karki</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Malireddi</surname> <given-names>R. K. S.</given-names>
</name>
<name>
<surname>Neale</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Vogel</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Yamamoto</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>The transcription factor IRF1 and guanylate-binding proteins target activation of the AIM2 inflammasome by Francisella infection</article-title>. <source>Nat. Immunol.</source> <volume>16</volume>, <fpage>467</fpage>&#x2013;<lpage>475</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ni.3118</pub-id>, PMID: <pub-id pub-id-type="pmid">25774715</pub-id></citation></ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marecic</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Shevchuk</surname> <given-names>O.</given-names>
</name>
<name>
<surname>Ozanic</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Mihelcic</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Steinert</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Begonja</surname> <given-names>A. J.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>Isolation of <italic>F. novicida</italic>-containing phagosome from infected human monocyte derived macrophages</article-title>. <source>Front. Cell. Infect. Microbiol.</source> <volume>7</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2017.00303</pub-id>, PMID: <pub-id pub-id-type="pmid">28725638</pub-id></citation></ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McGann</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Rozak</surname> <given-names>D. A.</given-names>
</name>
<name>
<surname>Nikolich</surname> <given-names>M. P.</given-names>
</name>
<name>
<surname>Bowden</surname> <given-names>R. A.</given-names>
</name>
<name>
<surname>Lindler</surname> <given-names>L. E.</given-names>
</name>
<name>
<surname>Wolcott</surname> <given-names>M. J.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>A novel brain heart infusion broth supports the study of common <italic>Francisella tularensis</italic> serotypes</article-title>. <source>J. Microbiol. Methods</source> <volume>80</volume>, <fpage>164</fpage>&#x2013;<lpage>171</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.mimet.2009.12.005</pub-id>, PMID: <pub-id pub-id-type="pmid">20005265</pub-id></citation></ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meunier</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Wallet</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Dreier</surname> <given-names>R. F.</given-names>
</name>
<name>
<surname>Costanzo</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Anton</surname> <given-names>L.</given-names>
</name>
<name>
<surname>R&#xfc;hl</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>Guanylate-binding proteins promote activation of the AIM2 inflammasome during infection with <italic>Francisella novicida</italic>
</article-title>. <source>Nat. Immunol.</source> <volume>16</volume>, <fpage>476</fpage>&#x2013;<lpage>484</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ni.3119</pub-id>, PMID: <pub-id pub-id-type="pmid">25774716</pub-id></citation></ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miller</surname> <given-names>W. L.</given-names>
</name>
<name>
<surname>Matewish</surname> <given-names>M. J.</given-names>
</name>
<name>
<surname>McNally</surname> <given-names>D. J.</given-names>
</name>
<name>
<surname>Ishiyama</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Anderson</surname> <given-names>E. M.</given-names>
</name>
<name>
<surname>Brewer</surname> <given-names>D.</given-names>
</name>
<etal/>
</person-group>. (<year>2008</year>). <article-title>Flagellin glycosylation in <italic>pseudomonas aeruginosa</italic> PAK requires the O-antigen biosynthesis enzyme WbpO</article-title>. <source>J. Biol. Chem.</source> <volume>283</volume>, <fpage>3507</fpage>&#x2013;<lpage>3518</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M708894200</pub-id>, PMID: <pub-id pub-id-type="pmid">18065759</pub-id></citation></ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mills</surname> <given-names>E. L.</given-names>
</name>
<name>
<surname>Kelly</surname> <given-names>B.</given-names>
</name>
<name>
<surname>O&#x2019;Neill</surname> <given-names>L. A. J.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Mitochondria are the powerhouses of immunity</article-title>. <source>Nat. Immunol.</source> <volume>18</volume>, <fpage>488</fpage>&#x2013;<lpage>498</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ni.3704</pub-id>, PMID: <pub-id pub-id-type="pmid">28418387</pub-id></citation></ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nagle</surname> <given-names>S. C.</given-names>
<suffix>Jr.</suffix>
</name>
<name>
<surname>Anderson</surname> <given-names>R. E.</given-names>
</name>
<name>
<surname>Gary</surname> <given-names>N. D.</given-names>
</name>
</person-group> (<year>1960</year>). <article-title>Chemically defined medium for the growth of <italic>Pasteurella tularensis</italic>
</article-title>. <source>J. Bacteriol.</source> <volume>79</volume>, <fpage>566</fpage>&#x2013;<lpage>571</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/jb.79.4.566-571.1960</pub-id>, PMID: <pub-id pub-id-type="pmid">14425793</pub-id></citation></ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakamura</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Shimizu</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Ikegaya</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Uda</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Watanabe</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Watarai</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Identification of pyrC gene as an immunosuppressive factor in <italic>Francisella novicida</italic> infection</article-title>. <source>Front. Cell. Infect. Microbiol.</source> <volume>12</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2022.1027424</pub-id>, PMID: <pub-id pub-id-type="pmid">36389167</pub-id></citation></ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakamura</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Shimizu</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Inagaki</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Okazaki</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Saha</surname> <given-names>S. S.</given-names>
</name>
<name>
<surname>Uda</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Identification of membrane-bound lytic murein transglycosylase A (MltA) as a growth factor for <italic>francisella novicida</italic> in a silkworm infection model</article-title>. <source>Front. Cell. Infect. Microbiol.</source> <volume>10</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2020.581864</pub-id>, PMID: <pub-id pub-id-type="pmid">33553001</pub-id></citation></ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakamura</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Shimizu</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Nishinakama</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Takahashi</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Arasaki</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Uda</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2024</year>). <article-title>A novel method of <italic>Francisella</italic> infection of epithelial cells using HeLa cells expressing fc gamma receptor</article-title>. <source>BMC Infect. Dis.</source> <volume>24</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12879-024-10083-y</pub-id>, PMID: <pub-id pub-id-type="pmid">39420255</pub-id></citation></ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakamura</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Shimizu</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Uda</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Watanabe</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Watarai</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Soluble lytic transglycosylase SLT of <italic>Francisella novicida</italic> is involved in intracellular growth and immune suppression</article-title>. <source>PloS One</source> <volume>14</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0226778</pub-id>, PMID: <pub-id pub-id-type="pmid">31877174</pub-id></citation></ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Noah</surname> <given-names>C. E.</given-names>
</name>
<name>
<surname>Malik</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Bublitz</surname> <given-names>D. C.</given-names>
</name>
<name>
<surname>Camenares</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Sellati</surname> <given-names>T. J.</given-names>
</name>
<name>
<surname>Benach</surname> <given-names>J. L.</given-names>
</name>
<etal/>
</person-group>. (<year>2010</year>). <article-title>GroEL and lipopolysaccharide from <italic>Francisella tularensis</italic> live vaccine strain synergistically activate human macrophages</article-title>. <source>Infect. Immun.</source> <volume>78</volume>, <fpage>1797</fpage>&#x2013;<lpage>1806</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.01135-09</pub-id>, PMID: <pub-id pub-id-type="pmid">20123721</pub-id></citation></ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Onishi</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Yamano</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Sato</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Matsuda</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Okamoto</surname> <given-names>K.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Molecular mechanisms and physiological functions of mitophagy</article-title>. <source>EMBO J.</source> <volume>40</volume>, <elocation-id>e104705</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.15252/embj.2020104705</pub-id>, PMID: <pub-id pub-id-type="pmid">33438778</pub-id></citation></ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ozanic</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Marecic</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Kwaik</surname> <given-names>Y. A.</given-names>
</name>
<name>
<surname>Santic</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>The divergent intracellular lifestyle of <italic>francisella tularensis</italic> in evolutionarily distinct host cells</article-title>. <source>PloS Pathog.</source> <volume>11</volume>, <elocation-id>e1005208</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.ppat.1005208</pub-id>, PMID: <pub-id pub-id-type="pmid">26633893</pub-id></citation></ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pavlik</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Velecka</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Spidlova</surname> <given-names>P.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Breaking the cellular defense: the role of autophagy evasion in <italic>Francisella</italic> virulence</article-title>. <source>Front. Cell. Infect. Microbiol.</source> <volume>14</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2024.1523597</pub-id>, PMID: <pub-id pub-id-type="pmid">39776438</pub-id></citation></ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>P&#xe9;rard</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Nader</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Levert</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Arnaud</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Carpentier</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Siebert</surname> <given-names>C.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Structural and functional studies of the metalloregulator Fur identify a promoter-binding mechanism and its role in <italic>Francisella tularensis</italic> virulence</article-title>. <source>Commun. Biol.</source> <volume>1</volume>, <fpage>93</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s42003-018-0095-6</pub-id>, PMID: <pub-id pub-id-type="pmid">30271974</pub-id></citation></ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prior</surname> <given-names>J. L.</given-names>
</name>
<name>
<surname>Prior</surname> <given-names>R. G.</given-names>
</name>
<name>
<surname>Hitchen</surname> <given-names>P. G.</given-names>
</name>
<name>
<surname>Diaper</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Griffin</surname> <given-names>K. F.</given-names>
</name>
<name>
<surname>Morris</surname> <given-names>H. R.</given-names>
</name>
<etal/>
</person-group>. (<year>2003</year>). <article-title>Characterization of the O antigen gene cluster and structural analysis of the O antigen of Francisella tularensis subsp. tularensis</article-title>. <source>J. Med. Microbiol.</source> <volume>52</volume>: <page-range>845&#x2013;851</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1099/jmm.0.05184-0</pub-id>, PMID: <pub-id pub-id-type="pmid">12972577</pub-id></citation></ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prok&#x161;ov&#xe1;</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Rehulkova</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Rehulka</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Lays</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Len&#x10d;o</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Stul&#xed;k</surname> <given-names>J.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Using proteomics to identify host cell interaction partners for VgrG and IglJ</article-title>. <source>Sci. Rep.</source> <volume>10</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-020-71641-3</pub-id>, PMID: <pub-id pub-id-type="pmid">32884055</pub-id></citation></ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ray</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Marteyn</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Sansonetti</surname> <given-names>P. J.</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>C. M.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Life on the inside: the intracellular lifestyle of cytosolic bacteria</article-title>. <source>Nat. Rev.</source> <volume>7</volume>, <fpage>333</fpage>&#x2013;<lpage>340</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nrmicro2112</pub-id>, PMID: <pub-id pub-id-type="pmid">19369949</pub-id></citation></ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Read</surname> <given-names>C. B.</given-names>
</name>
<name>
<surname>Ali</surname> <given-names>A. N.</given-names>
</name>
<name>
<surname>Stephenson</surname> <given-names>D. J.</given-names>
</name>
<name>
<surname>Macknight</surname> <given-names>H. P.</given-names>
</name>
<name>
<surname>Maus</surname> <given-names>K. D.</given-names>
</name>
<name>
<surname>Cockburn</surname> <given-names>C. L.</given-names>
</name>
<etal/>
</person-group>. (<year>2024</year>). <article-title>Ceramide-1-phosphate is a regulator of Golgi structure and is co-opted by the obligate intracellular bacterial pathogen <italic>Anaplasma phagocytophilum</italic>
</article-title>. <source>MBio.</source> <volume>15</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/mbio.00299-24</pub-id>, PMID: <pub-id pub-id-type="pmid">38415594</pub-id></citation></ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rigard</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Br&#xf6;ms</surname> <given-names>J. E.</given-names>
</name>
<name>
<surname>Mosnier</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Hologne</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Martin</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Lindgren</surname> <given-names>L.</given-names>
</name>
<etal/>
</person-group>. (<year>2016</year>). <article-title>
<italic>Francisella tularensis</italic> iglG belongs to a novel family of PAAR-like T6SS proteins and harbors a unique N-terminal extension required for virulence</article-title>. <source>PloS Pathog.</source> <volume>12</volume>, <elocation-id>e1005821</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.ppat.1005821</pub-id>, PMID: <pub-id pub-id-type="pmid">27602570</pub-id></citation></ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodriguez</surname> <given-names>S. A.</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>J. J.</given-names>
</name>
<name>
<surname>Davis</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Arulanandam</surname> <given-names>B. P.</given-names>
</name>
<name>
<surname>Klose</surname> <given-names>K. E.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Targeted inactivation of <italic>Francisella tularensis</italic> genes by group II introns</article-title>. <source>Appl. Environ. Microbiol.</source> <volume>74</volume>, <fpage>2619</fpage>&#x2013;<lpage>2626</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/AEM.02905-07</pub-id>, PMID: <pub-id pub-id-type="pmid">18310413</pub-id></citation></ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rowe</surname> <given-names>H. M.</given-names>
</name>
<name>
<surname>Huntley</surname> <given-names>J. F.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>From the Outside-In: The francisella tularensis envelope and virulence</article-title>. <source>Front Cell Infect Microbiol.</source> <volume>5</volume>, <elocation-id>94</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2015.00094</pub-id>, PMID: <pub-id pub-id-type="pmid">26779445</pub-id></citation></ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shimizu</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Otonari</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Suzuki</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Uda</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Watanabe</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Watarai</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Expression of <italic>Francisella</italic> pathogenicity island protein intracellular growth locus E (IglE) in mammalian cells is involved in intracellular trafficking, possibly through microtubule organizing center</article-title>. <source>Microbiol. Open</source> <volume>8</volume>, <elocation-id>e00684</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/mbo3.684</pub-id>, PMID: <pub-id pub-id-type="pmid">29978561</pub-id></citation></ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Silwal</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>J. K.</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>Y. J.</given-names>
</name>
<name>
<surname>Jo</surname> <given-names>E. K.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Mitochondrial reactive oxygen species: double-edged weapon in host defense and pathological inflammation during infection</article-title>. <source>Front. Immunol.</source> <volume>11</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2020.01649</pub-id>, PMID: <pub-id pub-id-type="pmid">32922385</pub-id></citation></ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sjodin</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Svensson</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Ohrman</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Ahlinder</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Lindgren</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Duodu</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2012</year>). <article-title>Genome characterisation of the genus <italic>Francisella</italic> reveals insight into similar evolutionary paths in pathogens of mammals and fish</article-title>. <source>BMC Genom.</source> <volume>13</volume>, <elocation-id>268</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/1471-2164-13-268</pub-id>, PMID: <pub-id pub-id-type="pmid">22727144</pub-id></citation></ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spidlova</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Stulik</surname> <given-names>J.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>
<italic>Francisella tularensis</italic> type VI secretion system comes of age</article-title>. <source>Virulence.</source> <volume>8</volume>, <fpage>628</fpage>&#x2013;<lpage>631</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/21505594.2016.1278336</pub-id>, PMID: <pub-id pub-id-type="pmid">28060573</pub-id></citation></ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spinelli</surname> <given-names>J. B.</given-names>
</name>
<name>
<surname>Haigis</surname> <given-names>M. C.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>The multifaceted contributions of mitochondria to cellular metabolism</article-title>. <source>Nat. Cell. Biol.</source> <volume>20</volume>, <fpage>745</fpage>&#x2013;<lpage>754</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41556-018-0124-1</pub-id>, PMID: <pub-id pub-id-type="pmid">29950572</pub-id></citation></ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Storek</surname> <given-names>K. M.</given-names>
</name>
<name>
<surname>Gertsvolf</surname> <given-names>N. A.</given-names>
</name>
<name>
<surname>Ohlson</surname> <given-names>M. B.</given-names>
</name>
<name>
<surname>Monack</surname> <given-names>D. M.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>cGAS and Ifi204 cooperate to produce type I IFNs in response to francisella infection</article-title>. <source>J. Immunol.</source> <volume>194</volume>, <fpage>3226</fpage>&#x2013;<lpage>3245</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.1402764</pub-id>, PMID: <pub-id pub-id-type="pmid">25710914</pub-id></citation></ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Su</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Gomez</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Kellum</surname> <given-names>J. A.</given-names>
</name>
<name>
<surname>Peng</surname> <given-names>Z.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Mitochondria ROS and mitophagy in acute kidney injury</article-title>. <source>Autophagy.</source> <volume>19</volume>, <fpage>401</fpage>&#x2013;<lpage>414</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/15548627.2022.2084862</pub-id>, PMID: <pub-id pub-id-type="pmid">35678504</pub-id></citation></ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tao</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Gong</surname> <given-names>T.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Golgi apparatus: an emerging platform for innate immunity</article-title>. <source>Trends. Cell. Biol.</source> <volume>30</volume>, <fpage>467</fpage>&#x2013;<lpage>477</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.tcb.2020.02.008</pub-id>, PMID: <pub-id pub-id-type="pmid">32413316</pub-id></citation></ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thomas</surname> <given-names>R. M.</given-names>
</name>
<name>
<surname>Titball</surname> <given-names>R. W.</given-names>
</name>
<name>
<surname>Oyston</surname> <given-names>P. C. F.</given-names>
</name>
<name>
<surname>Griffin</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Waters</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Hitchen</surname> <given-names>P. G.</given-names>
</name>
<etal/>
</person-group>. (<year>2007</year>). <article-title>The immunologically distinct O antigens from <italic>Francisella tularensis subspecies tularensis</italic> and <italic>Francisella novicida</italic> are both virulence determinants and protective antigens</article-title>. <source>Infect. Immun.</source> <volume>75</volume>, <fpage>371</fpage>&#x2013;<lpage>378</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.01241-06</pub-id>, PMID: <pub-id pub-id-type="pmid">17074846</pub-id></citation></ref>
<ref id="B65">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wawszczak</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Banaszczak</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Rastawicki</surname> <given-names>W.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Tularaemia-a diagnostic challenge</article-title>. <source>Ann. Agric. Environ. Med.</source> <volume>29</volume>, <fpage>12</fpage>&#x2013;<lpage>21</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.26444/aaem/139242</pub-id>, PMID: <pub-id pub-id-type="pmid">35352900</pub-id></citation></ref>
<ref id="B66">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weiss</surname> <given-names>D. S.</given-names>
</name>
<name>
<surname>Henry</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Monack</surname> <given-names>D. M.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>
<italic>Francisella tularensis</italic>: activation of the inflammasome</article-title>. <source>Ann. N Y Acad. Sci.</source> <volume>1105</volume>, <fpage>219</fpage>&#x2013;<lpage>237</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1196/annals.1409.005</pub-id>, PMID: <pub-id pub-id-type="pmid">17395724</pub-id></citation></ref>
<ref id="B67">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xia</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Meng</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Kari</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y.</given-names>
</name>
</person-group> (<year>2025</year>). <article-title>For better or worse: type I interferon responses in bacterial infection</article-title>. <source>Pathogens.</source> <volume>14</volume>, <elocation-id>229</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/pathogens14030229</pub-id>, PMID: <pub-id pub-id-type="pmid">40137714</pub-id></citation></ref>
<ref id="B68">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Shen</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Ran</surname> <given-names>Z.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Emerging views of mitophagy in immunity and autoimmune diseases</article-title>. <source>Autophagy.</source> <volume>18</volume>, <fpage>1</fpage>&#x2013;<lpage>15</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/15548627.2019.1603547</pub-id>, PMID: <pub-id pub-id-type="pmid">30951392</pub-id></citation></ref>
<ref id="B69">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Shen</surname> <given-names>Y.</given-names>
</name>
<etal/>
</person-group>. (<year>2025</year>). <article-title>
<italic>Staphylococcus aureus</italic> induces mitophagy via the HDAC11/IL10 pathway to sustain intracellular survival</article-title>. <source>J. Transl. Med.</source> <volume>23</volume>, <fpage>156</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12967-025-06161-7</pub-id>, PMID: <pub-id pub-id-type="pmid">39905391</pub-id></citation></ref>
<ref id="B70">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yeni</surname> <given-names>D. K.</given-names>
</name>
<name>
<surname>B&#xfc;y&#xfc;k</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Ashraf</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Shah</surname> <given-names>M. S. U. D.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Tularemia: a re-emerging tick-borne infectious disease</article-title>. <source>Folia Microbiol.</source> <volume>66</volume>, <fpage>1</fpage>&#x2013;<lpage>14</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s12223-020-00827-z</pub-id>, PMID: <pub-id pub-id-type="pmid">32989563</pub-id></citation></ref>
<ref id="B71">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Yao</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Qiu</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>Listeria Hijacks Host Mitophagy through a Novel Mitophagy receptor to Evade Killing</article-title>. <source>Nat. Immunol.</source> <volume>20</volume>, <fpage>433</fpage>&#x2013;<lpage>446</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41590-019-0324-2</pub-id>, PMID: <pub-id pub-id-type="pmid">30804553</pub-id></citation></ref>
</ref-list>
</back>
</article>